Opti-Harvest (OPHVW) S-131 Aug 22IPO registrationFinancial data

Company Profile

Cover

Cover	6 Months Ended
Cover	Jun. 30, 2022
Entity Addresses [Line Items]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	OPTI-HARVEST, INC.
Entity Central Index Key	0001753945
Entity Tax Identification Number	81-3007305
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1801 Century Park East
Entity Address, Address Line Two	Suite 520
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90067
City Area Code	(310)
Local Phone Number	788-0200
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Business Contact [Member]
Entity Addresses [Line Items]
Entity Address, Address Line One	1801 Century Park East
Entity Address, Address Line Two	Suite 520
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90067
Contact Personnel Name	Jonathan Destler

Balance Sheets

Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 729,000	$ 1,715,000	$ 403,000
Accounts receivable	9,000	18,000	1,000
Inventory	516,000
Prepaid expense and other current assets	45,000	87,000
Total Current Assets	1,299,000	1,820,000	404,000
Property and equipment, net of accumulated depreciation	1,287,000	1,158,000	363,000
Vendor deposits		277,000
Deferred offering costs	228,000	186,000
Total Assets	2,814,000	3,441,000	767,000
Current Liabilities:
Accounts payable and accrued expenses	1,794,000	986,000	618,000
Convertible notes payable, net of debt discount	2,772,000	1,265,000
Current portion of loan payable	13,000	8,000	7,000
Patent purchase obligation			100,000
Total Current Liabilities	4,579,000	2,259,000	725,000
Loan payable, less current portion	63,000	25,000	33,000
Note payable			38,000
Total Liabilities	4,642,000	2,284,000	796,000
Commitments and Contingencies
Shareholders’ Equity (Deficit)
Preferred stock, value
Common stock, value	3,000	3,000	3,000
Additional paid-in-capital	25,076,000	20,344,000	9,105,000
Accumulated deficit	(26,907,000)	(19,190,000)	(9,137,000)
Total Shareholders’ Equity (Deficit)	(1,828,000)	1,157,000	(29,000)
Total liabilities and Shareholders’ Equity (Deficit)	$ 2,814,000	$ 3,441,000	$ 767,000

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated depreciation	$ 824,000	$ 577,000	$ 278,000
Debt instrument, unamortized discount, current	$ 819,000	$ 2,326,000	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	33,736,399	32,405,146	28,956,158
Common stock, shares outstanding	33,736,399	32,405,146	28,956,158
Series A Preferred Stock [Member]
Preferred stock, shares issued	1	1	1
Preferred stock, shares outstanding	1	1	1

Statements of Operations

Statements of Operations - USD ($)	6 Months Ended		12 Months Ended
Statements of Operations - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net Sales	$ 20,000	$ 13,000	$ 40,000	$ 20,000
Cost of goods sold	26,000	50,000	102,000	115,000
Gross loss	(6,000)	(37,000)	(62,000)	(95,000)
Operating expenses:
Selling, general and administrative expense	4,120,000	3,536,000	6,591,000	1,467,000
Research and development expense	1,257,000	1,191,000	2,621,000	1,680,000
Amortization of intangible assets				42,000
Total operating expenses	5,377,000	4,727,000	9,212,000	3,189,000
Loss from operations	(5,383,000)	(4,764,000)	(9,274,000)	(3,284,000)
Interest expense	(1,723,000)	(3,000)	(817,000)
Gain on forgiveness of SBA PPP loan		38,000	38,000
Financing costs	(611,000)
Total other income (expense)	(2,334,000)	35,000
Net Loss	$ (7,717,000)	$ (4,729,000)	$ (10,053,000)	$ (3,284,000)
Loss per share – basic and diluted	$ (0.24)	$ (0.16)	$ (0.32)	$ (0.12)
Weighted average number of shares outstanding – basic and diluted	32,820,329	29,680,652	30,970,657	27,621,029

Statements of Changes in Shareh

Statements of Changes in Shareholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 3,000		$ 6,477,000	$ (5,853,000)	$ 627,000
Beginning balance, shares at Dec. 31, 2019	27,629,408	1
Fair value of common shares issued for services			115,000		115,000
Fair value of common shares issued for services, shares	57,500
Common shares issued in private offerings			2,513,000		2,513,000
Common shares issued in private offerings, shares	1,269,250
Net Loss				(3,284,000)	(3,284,000)
Ending balance, value at Dec. 31, 2020	$ 3,000		9,105,000	(9,137,000)	(29,000)
Ending balance, shares at Dec. 31, 2020	28,956,158	1
Fair value of common shares issued for services			1,652,000		1,652,000
Fair value of common shares issued for services, shares	826,000
Common shares issued in private offerings			4,794,000		4,794,000
Common shares issued in private offerings, shares	2,372,000
Net Loss				(4,729,000)	(4,729,000)
Fair value of vested stock options			322,000		322,000
Ending balance, value at Jun. 30, 2021	$ 3,000		15,873,000	(13,866,000)	2,010,000
Ending balance, shares at Jun. 30, 2021	32,154,158	1
Beginning balance, value at Dec. 31, 2020	$ 3,000		9,105,000	(9,137,000)	(29,000)
Beginning balance, shares at Dec. 31, 2020	28,956,158	1
Fair value of common shares issued for services			1,744,000		1,744,000
Fair value of common shares issued for services, shares	851,488
Net Loss				(10,053,000)	(10,053,000)
Fair value of vested options and warrants issued for services			1,768,000		1,768,000
Fair value of warrants recorded as debt discount			2,482,000		2,482,000
Common shares and warrants issued in private offerings			5,245,000		$ 5,245,000
Common shares and warrants issued in private offerings, shares	2,597,500
Common shares issued in the exercise of warrants, shares
Ending balance, value at Dec. 31, 2021	$ 3,000		20,344,000	(19,190,000)	$ 1,157,000
Ending balance, shares at Dec. 31, 2021	32,405,146	1
Fair value of common shares issued for services			968,000		$ 968,000
Fair value of common shares issued for services, shares	322,500				122,500
Common shares issued in private offerings			195,000		$ 195,000
Common shares issued in private offerings, shares	65,000
Net Loss				(7,717,000)	(7,717,000)
Fair value of vested options and warrants issued for services			1,402,000		1,402,000
Fair value of vested restricted stock units			75,000		75,000
Fair value of common shares issued for financing costs			611,000		611,000
Fair value of common shares issued for financing costs, shares	203,503
Common shares issued in the exercise of warrants			1,481,000		$ 1,481,000
Common shares issued in the exercise of warrants, shares	740,250
Ending balance, value at Jun. 30, 2022	$ 3,000		$ 25,076,000	$ (26,907,000)	$ (1,828,000)
Ending balance, shares at Jun. 30, 2022	33,736,399	1

Statements of Cash Flows

Statements of Cash Flows - USD ($)	6 Months Ended		12 Months Ended
Statements of Cash Flows - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities
Net loss	$ (7,717,000)	$ (4,729,000)	$ (10,053,000)	$ (3,284,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	247,000	156,000	299,000	265,000
Amortization of intangible assets				42,000
Amortization of debt discount	1,507,000		713,000
Financing costs	611,000
Change in inventory reserve		45,000	60,000
Fair value of common stock issued for services	968,000	1,652,000	1,744,000	115,000
Fair value of vested options and warrants	1,402,000	322,000	1,768,000
Fair value of vested restricted stock units	75,000
Gain on forgiveness of SBA PPP loan		(38,000)	(38,000)
Changes in operating assets and liabilities
Accounts receivable	9,000	1,000	(17,000)	(1,000)
Inventory	(486,000)	(64,000)	(60,000)
Prepaids and other current assets	42,000	(207,000)	(87,000)
Accounts payable and accrued expenses	808,000	4,000	368,000	359,000
Net cash used in operating activities	(2,534,000)	(2,858,000)	(5,303,000)	(2,504,000)
Cash Flows from Investing Activities
Purchase of property and equipment	(80,000)	(16,000)	(20,000)	(390,000)
Deposits on purchase of equipment			(1,351,000)
Net cash used in investing activities	(80,000)	(16,000)	(1,371,000)	(390,000)
Cash Flows from Financing Activities
Proceeds from sale of common stock	195,000	4,794,000	5,245,000	2,513,000
Proceeds from exercise of warrants	1,481,000
Proceeds from convertible notes payable			3,034,000
Proceeds from note payable				38,000
Deferred offering costs	(42,000)		(186,000)
Repayment of loans payable	(6,000)	(4,000)	(7,000)
Repayment of patent purchase obligation		(100,000)	(100,000)
Repayment of related parties				68,000
Net cash provided by financing activities	1,628,000	4,690,000	7,986,000	2,619,000
Net increase (decrease) in cash	(986,000)	1,816,000	1,312,000	(275,000)
Cash beginning of period	1,715,000	403,000	403,000	678,000
Cash end of period	729,000	2,219,000	1,715,000	403,000
Supplemental disclosures of cash flow information:
Cash paid for interest	3,000	3,000	3,000
Cash paid for income taxes
Non-Cash Investing and Financing Activities:
Fair value of warrants recorded as a debt discount			2,482,000
Transfer of deposits on purchase of equipment to property and equipment			1,074,000
Reclassification of vendor deposits to property and equipment	247,000
Reclassification of vendor deposits to inventory	30,000
Issuance of loan payable for vehicle purchase	$ 49,000			$ 40,000

Basis of Presentation and Liqui

Basis of Presentation and Liquidity	6 Months Ended	12 Months Ended
Basis of Presentation and Liquidity	Jun. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Liquidity	Note 1 – Basis of Presentation and Liquidity The accompanying interim condensed financial statements of Opti-Harvest, Inc. (the “Company”, “we”, “us”, or “our”), are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly our financial position at June 30, 2022 and the results of operations and cash flows for the six months ended June 30, 2022 and 2021. The balance sheet as of December 31, 2021 is derived from the Company’s audited financial statements included elsewhere in this filing. Certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. For further information, refer to the financial statements and the notes thereto included in the Company’s registration statement. The results of operations for the six months ended June 30, 2022 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2022. COVID-19 Considerations During the six months ended June 30, 2022, the COVID-19 pandemic did not have a material net impact on the Company’s operating results. In the future, the pandemic may cause reduced demand for the Company’s products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. The Company has not observed any material impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. The Company’s ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on its ability to protect its employees and its supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect its employees. Since the onset of the COVID-19 pandemic, the Company maintained the consistency of its operations. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to its workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact the Company’s operations. Going Concern The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed financial statements, during the six months ended June 30, 2022, the Company recorded a net loss of $ 7,717,000 , used cash in operations of $ 2,534,000 and had a shareholders’ deficit of $ 1,828,000 on June 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2021 financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. At June 30, 2022, the Company had cash on hand in the amount of $ 729,000 1,105,000 Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our shareholders, in case or equity financing.	Note 1 – Operations and Liquidity Basis of Presentation and Liquidity Opti-Harvest, Inc. (“Opti-Harvest” or “the Company”) is an agricultural innovation company with products backed by a portfolio of patented and patent pending technologies focused on solving several critical challenges faced by agribusinesses: maximizing crop yield, accelerating crop growth, optimizing land and water resources, reducing labor costs and mitigating negative environmental impacts. Our advanced agriculture technology (Opti-Filter™) and precision farming (Opti-View™) platforms, enable commercial growers and home gardeners to harness, optimize and better utilize sunlight, the planet’s most fundamental and renewable natural resource. Our sustainable agricultural technology platform is powered by the sun. It maximizes a free and renewable resource with no need for additional chemicals or fertilizers. Opti-Harvest was formed in the State of Delaware on June 20, 2016. Our principal executive offices are located at 1801 Century Park East, Suite 520, Los Angeles, California 90067. Our website address is www.opti-harvest.com. COVID-19 Considerations During the year ended December 31, 2021, the COVID-19 pandemic did not have a material net impact on the Company’s operating results. In the future, the pandemic may cause reduced demand for the Company’s products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. The Company has not observed any material impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. The Company’s ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on its ability to protect its employees and its supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect its employees. Since the onset of the COVID-19 pandemic, the Company maintained the consistency of its operations. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to its workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact the Company’s operations. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, during the year ended December 31, 2021, the Company recorded a net loss of $ 10.1 5.3 At December 31, 2021, the Company had cash on hand in the amount of $ 1.7

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended	12 Months Ended
Significant Accounting Policies	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 – Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Inventory Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and our ability to sell the product(s) concerned. Demand for our products can fluctuate significantly. Factors that could affect demand for our products include unanticipated changes in consumer preferences, general market conditions or other factors, which may result in cancellations of advance orders or a reduction in the rate of reorders placed by customers. Additionally, our management’s estimates of future product demand may be inaccurate, which could result in an understated or overstated provision required for excess and obsolete inventory. At June 30, 2022, the Company determined that no reserve for obsolete inventory was necessary. Deferred Offering Costs Deferred offering costs consist principally of legal, accounting, and underwriters’ fees incurred related to equity financings. These deferred offering costs are deferred and then charged against the gross proceeds received once the equity financing occurs or are charged to expense if the financing does not occur. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfillment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis. Loss per Common Share Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common shareholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share is computed by dividing the net income applicable to common shareholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. For the six months ended June 30, 2022 and 2021, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following: Schedule of Anti-Dilutive Securities of Earning Per Share June 30, 2022 June 30, 2021 Warrants 5,870,610 2,264,375 Options 4,540,000 4,325,000 Restricted stock units 200,000 - Senior convertible notes 1,627,522 - Series A Preferred 1 1 Total 12,238,133 6,789,376 Anti-dilutive securities 12,238,133 6,789,376 Stock Compensation Expense The Company periodically issues stock options to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation The fair value of each option or warrant grant is estimated using the Black-Scholes option-pricing model. The Company is a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies within the agriculture technology industry with characteristics similar to the Company. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain-vanilla” options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. During the six months ended June 30, 2022 and 2021, common shares of the Company were not publicly traded. As such, during the period, the Company estimates the fair value of common stock using an appropriate valuation methodology, in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation. Each valuation methodology includes estimates and assumptions that require the Company’s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, guideline public company information, the prices at which the Company sold its common stock to third parties in arms’ length transactions, the rights and preferences of securities senior to the Company’s common stock at the time, and the likelihood of achieving a liquidity event such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in different fair values of stock options at each valuation date, as applicable. Research and Development Research and development costs include advisors, consultants, software licensing, product design and development, data monitoring and collection, field trial installations, and travel related expenses. Research and development costs are expensed as incurred. During the six months ended June 30, 2022 and 2021, research and development costs were approximately $ 1,257,000 1,191,000 Fair Value of Financial Instruments The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The carrying amounts of financial assets and liabilities, such as cash, accounts receivable, accounts payable and accrued liabilities, and patent purchase obligation approximate their fair values because of the short maturity of these instruments. The carrying values of loan and convertible notes payables approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. Recent Accounting Pronouncements In September 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures. Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements. Concentration Risks Cash includes cash on hand and cash in banks and are reported as “Cash” in the balance sheets. The balance of cash on hand is not insured by the Federal Deposit Insurance Corporation. The balance of cash in banks is insured by the Federal Deposit Insurance Corporation for up to $250,000. The Company performs a regular review of customer activity and associated credit risks and does not require collateral or other arrangements. Five customers accounted for 24 21 16 12 10 10 The Company’s uses two vendors to manufacture its products available for sale, inventory, and our products used in field trials for research and development purposes. Segment Reporting The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.	Note 2 – Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Inventory Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and our ability to sell the product(s) concerned. Demand for our products can fluctuate significantly. Factors that could affect demand for our products include unanticipated changes in consumer preferences, general market conditions or other factors, which may result in cancellations of advance orders or a reduction in the rate of reorders placed by customers. Additionally, our management’s estimates of future product demand may be inaccurate, which could result in an understated or overstated provision required for excess and obsolete inventory. At December 31, 2021, the Company fully reserved its inventory balance on hand based on its estimate of obsolete inventory. Property and Equipment Property and equipment are stated at cost. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized, and expenditures for repairs and maintenance are charged to expense as incurred. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets as follows: Schedule of Estimated Useful Lives of Property and Equipment Property and Equipment Type Years of Depreciation Tool and Molds 2 3 years Vehicle 5 years Office equipment 3 years Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 2021 and 2020, the Company determined there were no indicators of impairment of its property and equipment. Deferred Offering Costs Deferred offering costs consist principally of legal, accounting, and underwriters’ fees incurred related to equity financings. These deferred offering costs are deferred and then charged against the gross proceeds received once the equity financing occurs or are charged to expense if the financing does not occur. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. The Company does not allow for returns, except for product damaged during customer delivery. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis. Loss per Common Share Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. For the years ended December 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following: Schedule of Anti-Dilutive Securities of Earning Per Share December 31, 2021 December 31, 2020 Warrants 6,578,360 1,278,375 Options 4,415,000 - Senior convertible notes 769,240 - Series A Preferred 1 1 Total 11,762,601 1,278,376 Stock Compensation Expense The Company periodically issues stock options to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation The fair value of each option or warrant grant is estimated using the Black-Scholes option-pricing model. The Company is a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies within the agriculture technology industry with characteristics similar to the Company. The expected term of the Company’s stock options has been determined utilizing the “simplified” method for awards that qualify as “plain-vanilla” options. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. During the year ended December 31, 2021 and 2020, common shares of the Company were not publicly traded. As such, during the period, the Company estimated the fair value of common stock using an appropriate valuation methodology, in accordance with the framework of the American Institute of Certified Public Accountants’ Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation. Each valuation methodology includes estimates and assumptions that require the Company’s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, guideline public company information, the prices at which the Company sold its common stock to third parties in arms’ length transactions, the rights and preferences of securities senior to the Company’s common stock at the time, and the likelihood of achieving a liquidity event such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in different fair values of stock options at each valuation date, as applicable. Income Taxes Income tax expense is based on pretax financial accounting income. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company has recorded a valuation allowance against its deferred tax assets as of December 31, 2021, and 2020. The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50 percent likely of being realized upon settlement. The Company classifies the liability for unrecognized tax benefits as current to the extent that the Company anticipates payment (or receipt) of cash within one year. Interest and penalties related to uncertain tax positions are recognized in the provision for income taxes. Research and Development Research and development costs include advisors, consultants, legal, software licensing, product design and development, data monitoring and collection, field trial installations, and travel related expenses. Research and development costs are expensed as incurred. During the years ended December 31, 2021 and 2020, research and development costs were $ 2,621,000 1,680,000 Fair Value of Financial Instruments The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s assumptions. The carrying amounts of financial assets and liabilities, such as cash, accounts receivable, accounts payable and accrued liabilities, and patent purchase obligation approximate their fair values because of the short maturity of these instruments. The carrying values of loan and note payables approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. Recent Accounting Pronouncements In September 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40).” ASU 2020-06 reduces the number of accounting models for convertible debt instruments by eliminating the cash conversion and beneficial conversion models. The diluted net income per share calculation for convertible instruments will require the Company to use the if-converted method. For contracts in an entity’s own equity, the type of contracts primarily affected by this update are freestanding and embedded features that are accounted for as derivatives under the current guidance due to a failure to meet the settlement conditions of the derivative scope exception. This update simplifies the related settlement assessment by removing the requirements to (i) consider whether the contract would be settled in registered shares, (ii) consider whether collateral is required to be posted, and (iii) assess shareholder rights. ASU 2020-06 is effective January 1, 2024, for the Company and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. Effective January 1, 2021, the Company early adopted ASU 2020-06 and that adoption did not have an impact on our financial statements and related disclosures. Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements. Concentration Risks Cash includes cash on hand and cash in banks and are reported as “Cash” in the balance sheets. The balance of cash on hand is not insured by the Federal Deposit Insurance Corporation. The balance of cash in banks is insured by the Federal Deposit Insurance Corporation for up to $ 250,000 The Company performs a regular review of customer activity and associated credit risks and does not require collateral or other arrangements. One customer accounted for 45% 92% The Company’s currently uses one vendor to manufacturing the majority of its products, including products developed for the Company’s research and development activities. Segment Reporting The Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

Property and Equipment

Property and Equipment	6 Months Ended	12 Months Ended
Property and Equipment	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 4 – Property and Equipment Property and equipment is comprised of the following: Schedule of Property and Equipment June 30, 2022 December 31, 2021 Tools and molds $ 1,990,000 $ 1,682,000 Computer equipment 8,000 8,000 Vehicles 113,000 45,000 Total cost 2,111,000 1,735,000 Accumulated depreciation (824,000 ) (577,000 ) Net book value $ 1,287,000 $ 1,158,000 Depreciation expense for the six months ended June 30, 2022 and 2021 was $ 247,000 156,000 49,000 247,000	Note 3 – Property and Equipment Property and equipment consist of the following at December 31, 2021 and 2020: Schedule of Property and Equipment 2021 2020 Tools and molds $ 1,682,000 $ 592,000 Office equipment 8,000 4,000 Vehicles 45,000 45,000 Total cost 1,735,000 641,000 Less: accumulated depreciation and amortization (577,000 ) (278,000 ) Property and equipment, net $ 1,158,000 $ 363,000 Depreciation expense for the years ended December 31, 2021 and 2020, was $ 299,000 265,000

Earnout and Royalty Obligations

Earnout and Royalty Obligations	12 Months Ended
Earnout and Royalty Obligations	Dec. 31, 2021
Earnout And Royalty Obligations
Earnout and Royalty Obligations	Note 4 – Earnout and Royalty Obligations DisperSolar LLC (Related Party) On April 7, 2017 (as amended on December 6, 2018), the Company and DisperSolar LLC (the “Seller”), a California limited liability company, entered into a Patent Purchase Agreement (the “Agreement”) pursuant to which the Company acquired certain patents (intellectual property) of the Seller. The Seller developed the patents for harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants. Per the Agreement, the Company was obligated to pay milestone payments, earnout payments, and royalties. As of December 31, 2020, the remaining purchase obligation was $ 100,000 100,000 Earnout Payments The Company is obligated to pay total earnout payments of $ 800,000 1.6 Royalties The Company will pay to Seller royalties as follows: (i) Following the recognition by the Company of the first $ 1.6 30 (ii) Once Purchaser has paid to Seller an aggregate amount in royalties of $ 30 4.75% As of December 31, 2021 and December 31, 2020, the Company recorded no earnout or royalties payment obligations as no gross margin was realized. Strategic Transaction The Company will pay to Seller 7.6% Strategic Transaction Consideration. “Strategic Transaction Consideration” means any cash consideration and the fair market value of any non-cash consideration paid to the Company by any acquirer as consideration for the Strategic Transaction, less the costs and expenses incurred by Purchaser for the purpose of consummating the Strategic Transaction. The Company will pay to Seller a percentage of all license consideration received by Purchaser as follows: (i) 3.8% 50 (ii) 5.7% 100 50 150 (iii) 7.6% 150 Inventor Royalty (Related Party) On July 5, 2019, the Company and Nicholas Booth (“Mr. Booth”) entered into a Royalty Agreement. Mr. Booth is a member of Dispersolar, LLC and a named inventor of the acquired patents from Dispersolar, LLC discussed above. Effective July 1, 2021, Mr. Booth was employed by the Company as its Chief Technology Officer. The Company will pay Mr. Booth a percentage of all License Consideration received by the Company as follows: (a) Once the Company has paid to DisperSolar an aggregate amount in royalties of $ 30 0.25% (b) Opti-Harvest will pay to Booth a percentage of all License Consideration received by Purchaser on the same terms as payable by the Company to DisperSolar under the Agreement, except that the percentages of License Consideration due to Booth shall be as follows: (a) 0.4% (b) 0.2% 50 (c) 0.3% 100 50 150 (d) 0.4% 150 As of December 31, 2021 and December 31, 2020, no amounts were due for earnouts or royalties. Both Yosepha Shahak Ravid and Nicholas Booth are members of the Seller, and are named inventors of the acquired patents from the Seller, discussed above. Effective July 1, 2021, Ms. Shahak Ravid, our Chief Science Officer, and Mr. Booth, our Chief Technology Officer, were employed by the Company.

Senior Convertible Notes Payabl

Senior Convertible Notes Payable and Warrants	6 Months Ended	12 Months Ended
Senior Convertible Notes Payable and Warrants	Jun. 30, 2022	Dec. 31, 2021
Senior Convertible Notes Payable And Warrants
Senior Convertible Notes Payable and Warrants	Note 6 – Senior Convertible Notes Payable and Warrants Senior convertible notes payable is comprised of the following: Schedule of Senior Convertible Notes Payable June 30, 2022 December 31, 2021 Senior convertible notes payable $ 3,591,000 $ 3,591,000 Less debt discount (819,000 ) (2,326,000 ) Total senior convertible notes payable, net $ 2,772,000 $ 1,265,000 During the year ended December 31, 2021, the Company sold approximately $ 3,591,000 3,591,235 3,034,000 15 539,000 18,000 115 3.00 13.6 2.5 3,591,000 The holder of the Warrants shall have the right to purchase up to the number of shares that equals the quotient obtained by dividing: (i) the Warrant Coverage Amount, by (ii) the Conversion Price. The “Warrant Coverage Amount” shall mean the amount obtained by multiplying: (A) one hundred percent (100%); by (B) aggregate principal amount of the Holder’s Note(s). The conversion price in effect on any Conversion Date shall be equal to 80 Each Note is convertible, in the sole discretion of the holder of the Note, into shares of our common stock at a purchase price equal to 80 3.00 15 12 The Notes mature 12 10 December 15, 2021. Additionally, each Warrant contains a cashless exercise provision, which is effective if the shares underlying the Warrant are not covered by a registration statement 6 months from the date of issuance of the Warrant. 203,503 611,000 3.00 611,000 The shares of common stock underlying the Notes and the Warrants are subject to registration rights, and such shares must be registered within 90 days after the effectiveness of the Company’s initial public offering. If the Company fails to register the shares within 90 days, the Company agreed to pay a penalty of a cash payment equal to 0.02857% of the principal amount and interest due and owing under any Note held by the Holder or that number shares of common stock of the Company equal 1% of the shares of common stock underlying any Note and Warrant held by the Holder, in total amount per week paid in, whichever is greater. Each Note and Warrant holder has (i) the right of first refusal to purchase up to 20 The total of the original issue discount of $ 539,000 18,000 2.5 3.0 2.3 1.5 819,000 The accrued interest balance was $ 101,000 214,000 315,000 As of June 30, 2022, 1,627,522	Note 5 – Senior Convertible Notes Payable and Warrants Senior convertible notes payable is comprised of the following: Schedule of Senior Convertible Notes Payable December 31, 2021 December 31, 2020 Senior convertible notes payable $ 3,591,000 $ - Less debt discount (2,326,000 ) - Total senior convertible notes payable, net $ 1,265,000 $ - During the year ended December 31, 2021, the Company sold approximately $ 3,591,000 3,591,235 3,034,000 15 539,000 18,000 115 6.00 13.6 2.5 6.00 6.90 115 3.0 110 0 0.53 0.66 The holder of the Warrants shall have the right to purchase up to the number of shares that equals the quotient obtained by dividing: (i) the Warrant Coverage Amount, by (ii) the Conversion Price. The “Warrant Coverage Amount” shall mean the amount obtained by multiplying: (A) one hundred percent (100%); by (B) aggregate principal amount of the Holder’s Note(s). The conversion price in effect on any Conversion Date shall be equal to 80 Each Note is convertible, in the sole discretion of the holder of the Note, into shares of our common stock at a purchase price equal to 80 6.00 15 12 The Notes mature 12 10 December 15, 2021. Additionally, each Warrant contains a cashless exercise provision, which is effective if the shares underlying the Warrant are not covered by a registration statement 6 months from the date of issuance of the Warrant. The shares of common stock underlying the Notes and the Warrants are subject to registration rights, and such shares must be registered within 90 days after the effectiveness of the Company’s initial public offering. If the Company fails to register the shares within 90 days, the Company agreed to pay a penalty of a cash payment equal to 0.02857% of the principal amount and interest due and owing under any Note held by the Holder or that number shares of common stock of the Company equal 1% of the shares of common stock underlying any Note and Warrant held by the Holder, in total amount per week paid in, whichever is greater. Each Note and Warrant holder has (i) the right of first refusal to purchase up to 20 Both the original issue discount of $ 539,000 18,000 2.5 3.0 713,000 2.3 During the years ended December 31, 2021, the Company added $ 101,000 101,000 As of December 31, 2021, 802,685

Note Payable

Note Payable	12 Months Ended
Note Payable	Dec. 31, 2021
Debt Disclosure [Abstract]
Note Payable	Note 6 – Note Payable On April 27, 2020, the Company was granted a loan (the “PPP loan”) from Chase Bank in the aggregate amount of $ 38,000 38,000 38,000

Loans payable

Loans payable	6 Months Ended	12 Months Ended
Loans payable	Jun. 30, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Loans payable	Note 7 – Loans payable Loans payable is comprised of the following: Schedule of Loans Payable June 30, 2022 December 31, 2021 Loans payable $ 76,000 $ 33,000 Less current portion (13,000 ) (8,000 ) Noncurrent portion $ 63,000 $ 25,000 On November 20, 2020, the Company financed the purchase of a vehicle for $ 40,000 59 4.49 745 33,000 On January 20, 2022, the Company financed the purchase of second vehicle for $ 49,000 71 15.54 1,066 6,000 76,000	Note 7 – Loan payable Loans payable Schedule of Loans Payable On November 20, 2020, the Company financed the purchase of a vehicle for $ 40,000 59 4.49 745 secured by the purchased vehicle. 40,000 7,000 7,000 33,000 8,000

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit)	6 Months Ended	12 Months Ended
Shareholders’ Equity (Deficit)	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Shareholders’ Equity (Deficit)	Note 8 – Shareholders’ Equity (Deficit) Common Shares Issued on Exercise of Warrants During the six months ended June 30, 2022, the Company temporarily reduced the exercise price of certain warrants issued as part of the Company’s $ 2.00 3.00 2.00 1.5 740,250 740,250 2.00 Common Shares Issued on Private Offerings During the six months ended June 30, 2022, the Company received net proceeds of approximately $ 195,000 65,000 3.00 3.00 4.00 December 31, 2023 32,500 During the six months ended June 30, 2021, the Company received net proceeds of approximately $ 4.8 2,372,000 2.00 2.00 3.00 December 31, 2022 Common Shares Issued for Financing Costs On May 16, 2022, the Company entered into an amendment (see Note 6) to extend the call provisions in its senior secured convertible notes to June 15, 2022, in exchange for issuing its senior convertible note holders an aggregate of 203,503 611,000 3.00 611,000 Common Shares Issued for Services During the six months ended June 30, 2022, the Company entered into various consulting agreements with third parties (“Consultants”) pursuant to which these Consultants provided business development, sales promotion, introduction to new business opportunities, strategic analysis and sales and marketing activities. In addition, the Company issued shares to a director for board service. During the six months ended June 30, 2022, the Company issued 122,500 368,000 200,000 600,000 During the six months ended June 30, 2021, the Company entered into various consulting agreements with third parties (“Consultants”) pursuant to which these Consultants provided business development, sales promotion, introduction to new business opportunities, strategic analysis and sales and marketing activities. In addition, the Company issued shares to a director for board service. During the six months ended June 30, 2021, the Company issued 826,000 1.7 Summary of Restricted Stock Units On May 17, 2022, the Company granted an aggregate of 200,000 600,000 10 no 75,000 525,000 Summary of Warrants A summary of warrants for the six months ended June 30, 2022 is as follows: Summary of Warrants Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2021 6,578,360 $ 4.97 Warrants granted 32,500 4.00 Warrants exercised (740,250 ) 2.00 Warrants expired or forfeited - - Balance outstanding, June 30, 2022 5,870,610 $ 3.28 Balance exercisable, June 30, 2022 5,770,610 $ 3.27 During the six months ended June 30, 2022, the Company received proceeds of approximately $ 1.5 740,250 740,250 2.00 During the six months ended June 30, 2022, the Company recognized $ 66,000 27,000 As of June 30, 2022, the outstanding and exercisable warrants have an intrinsic value of $ 200,000 200,000 3.00 Summary of Options A summary of stock options for the six months ended June 30, 2022 is as follows: Summary of Options Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2021 4,415,000 $ 2.00 Options granted 175,000 2.00 Options exercised - - Options expired or forfeited (50,000 ) 2.00 Balance outstanding, June 30, 2022 4,540,000 $ 2.00 Balance exercisable, June 30, 2022 1,535,833 $ 2.00 Information relating to outstanding options at June 30, 2022, summarized by exercise price, is as follows: Summary of Outstanding Options Exercise Price Outstanding Exercisable Weighted Weighted Exercise Price Life Average Average Per Share Shares (Years) Exercise Price Shares Exercise Price $ 2.00 4,540,000 8.52 $ 2.00 1,535,833 $ 2.00 4,540,000 8.52 $ 2.00 1,535,833 $ 2.00 On May 9, 2022, the Employment Agreement with Steve Handy, the Company’s Chief Financial Officer and Director of Operations was ratified, confirmed, and approved. The Employment Agreement is for a two-year period with an initial base salary of $ 220,000 per annum and increased by 5% on the first anniversary of the Employment Agreement. The Employment Agreement includes a cash severance provision of $ 100,000 if Mr. Handy’s employment is terminated without cause. The Company granted Mr. Handy stock options to purchase 100,000 shares of common stock under the Company’s 2022 Stock Incentive Plan, at an exercise price of $ 2.00 per common share, with a vesting period of two years, and an expiration period of five years. The total fair value of these options at grant date was approximately $ 220,000 , which was determined using a Black-Scholes-Merton option pricing model with the following assumptions: fair value of our stock price of $ 3.00 per share, based on the Company’s current private offering price, the expected term of three years, volatility of 108 %, dividend rate of 0 %, and risk-free interest rate of 2.81 %. During the six months ended June 30, 2022, the Company granted employees aggregate options to purchase 75,000 shares of common stock under the Company’s 2022 Stock Incentive Plan, at an exercise price of $ 2.00 per common share, with a vesting period of twelve months, and an expiration period of five years. The total fair value of these options at grant date was approximately $ 306,000 , which was determined using a Black-Scholes-Merton option pricing model with the following weighted average assumptions: fair value of our stock price of $ 5.00 per share, based on the most recent valuation report, and valuation discussions with our former underwriters pursuant to our recently withdrawn initial public offering, and the Company’s current private offering price, the expected term of three years, volatility of 115 %, dividend rate of 0 %, and risk-free interest rate of 1.63 %. During the six months ended June 30, 2022, the Company recognized approximately $ 1,337,000 5,269,000 As of June 30, 2022, the outstanding and exercisable options have an intrinsic value of $ 4,540,000 1,536,000 3.00	Note 8 – Shareholders’ Equity Shareholders’ Equity (Deficit) The following description summarizes the material terms of our capital stock. Our authorized capital stock consists of 100,000,000 0.0001 1,000,000 1 0.0001 32,405,146 1 Undesignated Preferred Stock Under the terms of our Certificate of Incorporation, our board of directors is authorized to issue shares of our undesignated preferred stock in one or more series without shareholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a shareholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible future acquisitions and other corporate purposes, will affect, and may adversely affect, the rights of holders of common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock on the rights of holders of common stock until our board of directors determines the specific rights attached to that preferred stock. The effects of issuing preferred stock could include one or more of the following: ● restricting dividends on the common stock; ● diluting the voting power of the common stock; ● impairing the liquidation rights of the common stock; or ● delaying or preventing changes in control or management of our company. Once our board of directors approves the rights and preferences for a series of preferred stock, we will file a Certificate of Designation for such series of preferred stock with the Delaware Secretary of State formally establishing such rights and preferences. Series A Preferred Stock; Common Stock Voting Except as set forth below, each holder of Series A preferred stock has the same rights as holders of common stock and shall be entitled to notice of any shareholders’ meeting. They shall also be entitled to vote with the holders of common stock, and not as a separate class, except as may otherwise be required by law. Except as set forth below, each shareholder shall be entitled to one (1) vote for each share of stock outstanding. Except as set forth below or otherwise provided by the law of the State of Delaware, any corporate action to be taken shall be authorized by a majority of the votes cast by the shareholders. There are no cumulative rights to voting. Each share of Series A preferred stock is entitled to the number of votes equal to 110% of the number of votes of the common stock issued and outstanding. Additionally, for as long as any shares of Series A preferred stock are outstanding, the holders of Series A preferred stock shall be entitled to elect one director, or the Series A Director. Protective Provisions For as long as any shares of Series A preferred stock are outstanding, we must obtain the approval of at least a majority of the holders of the outstanding shares of preferred stock, voting as a separate class, to: ● Amend our articles of incorporation or, unless approved by our board of directors, including by the Series A Director, amend our bylaws; ● Change or modify the rights, preferences or other terms of the Series A preferred stock, or increase or decrease the number of authorized shares of Series A preferred stock; ● Reclassify or recapitalize any outstanding equity securities, or, unless approved by our board of directors, including by the Series A Director, authorize or issue, or undertake an obligation to authorize or issue, any equity securities or any debt securities convertible into or exercisable for any equity securities (other than the issuance of stock-options or securities under any employee option or benefit plan); ● Authorize or effect any transaction constituting a Deemed Liquidation (as defined in this subparagraph), or any other merger or consolidation of the Company, where a Deemed Liquidation shall mean: (1) the closing of the sale, transfer or other disposition of all or substantially all of the Company’s assets (including an irrevocable or exclusive license with respect to all or substantially all of the Company’s intellectual property); (2) the consummation of a merger, share exchange or consolidation with or into any other corporation, limited liability company or other entity (except one in which the holders of capital stock of the Company as constituted immediately prior to such merger, share exchange or consolidation continue to hold at least 50% of the voting power of the capital stock of the Company or the surviving or acquiring entity (or its parent entity)), (3) authorizing or effecting any transaction liquidation, dissolution or winding up of the Company, either voluntary or involuntary; provided, however ● Increase or decrease the size of our board of directors as provided in our bylaws or remove the Series A Director (unless approved by our board of directors, including the Series A Director); ● Declare or pay any dividends or make any other distribution with respect to any class or series of capital stock (unless approved by our board of directors, including the Series A Director); ● Redeem, repurchase or otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any outstanding shares of capital stock (other than the repurchase of shares of common stock from employees, consultants or other service providers pursuant to agreements approved by our board of directors under which the Company has the option to repurchase such shares at no greater than original cost upon the occurrence of certain events, such as the termination of employment) (unless approved by our board of directors, including the Series A Director); ● Create or amend any stock option plan of the Company, if any (other than amendments that do not require approval of the shareholders under the terms of the plan or applicable law) or approve any new equity incentive plan; ● Replace the President and/or Chief Executive Officer of the Company (unless approved by our board of directors, including the Series A Director); ● Transfer assets to any subsidiary or other affiliated entity (unless approved by our board of directors, including the Series A Director); ● Issue, or cause any subsidiary of the Company to issue, any indebtedness or debt security, other than trade accounts payable and/or letters of credit, performance bonds or other similar credit support incurred in the ordinary course of business, or amend, renew, increase or otherwise alter in any material respect the terms of any indebtedness previously approved or required to be approved by the holders of the Series A preferred stock (unless approved by our board of directors, including the Series A Director); ● Modify or change the nature of the Company’s business; ● Acquire, or cause a subsidiary of the Company to acquire, in any transaction or series of related transactions, the stock or any material assets of another person, or enter into any joint venture with any other person (unless approved by our board of directors, including the Series A Director); or ● Sell, transfer, license, lease or otherwise dispose of, in any transaction or series of related transactions, any material assets of the Company or any subsidiary outside the ordinary course of business (unless approved by our board of directors, including the Series A Director). Dividends Subject to the rights of the preferred shareholders set forth in “Protective Provisions”, our board of directors shall have full power and discretion, to determine out of legally available funds what, if any, dividends or distributions shall be declared and paid. Dividends may be paid in cash, in property, or in shares of common stock. Shares of common stock and Series A preferred stock are treated equally and ratably, on a per share basis, with respect to any dividend or distribution from us. If a dividend is paid in the form of shares of common stock or rights to acquire common stock, the holders of common stock and Series A preferred stock shall both receive common stock or rights to acquire common stock. No dividends shall be declared or payable in the form of Series A preferred stock. Liquidation Rights If there is a liquidation, dissolution or winding up of the Company, holders of our common stock and Series A preferred stock would be entitled to share in our assets remaining after the payment of liabilities equally and ratably, on a per share basis. Conversion Voluntary Conversion: Each share of Series A preferred stock shall be convertible into one fully paid and nonassessable share of common stock at the option of the holder. Other Provisions Holders of our common stock and Series A preferred stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable to the common stock or Series A preferred stock. Common shares issued on private offerings During the years ended December 31, 2021 and 2020, the Company received net proceeds of $ 5.2 2.5 2,597,500 1,269,250 2.00 2.00 3.00 December 31, 2022 Common shares issued for services The Company entered into various consulting agreements with third parties (“Consultants”) pursuant to which these Consultants provided business development, sales promotion, introduction to new business opportunities, strategic analysis and sales and marketing activities. During the year ended December 31, 2021, the Company issued 851,488 1.7 2.05 57,500 115,000 2.00 Summary of Warrants A summary of warrants for the years ended December 31, 2021 and 2020, is as follows: Summary of Warrants Weighted Average Number of Exercise Warrants Price Balance outstanding, December 31, 2019 643,750 $ 3.00 Warrants granted 634,625 3.00 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2020 1,278,375 3.00 Warrants granted 5,299,985 5.45 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2021 6,578,360 $ 4.97 Balance exercisable, December 31, 2021 6,378,360 $ 5.00 Information relating to outstanding warrants at December 31, 2021, summarized by exercise price, is as follows: Summary of Outstanding Warrants Exercise Price Outstanding Exercisable Exercise Price Per Share Share Life (Years) Weighted Average Exercise Price Shares Weighted Average Exercise Price $ 2.00 200,000 2.50 $ 3.00 200,000 $ 2.00 $ 3.00 2,587,125 1.00 $ 3.00 2,587,125 $ 3.00 $ 4.00 200,000 2.50 $ 4.00 - $ 4.00 $ 6.61 3,591,235 2.76 $ 6.61 3,591,235 $ 6.61 6,578,360 2.06 $ 4.97 6,378,360 $ 5.00 During the year ended December 31, 2021, the Company issued warrants exercisable into an aggregate of 5,299,985 2.06 8.2 7.9 6.00 Warrants Issued in Private Offering In conjunction with the sale of the common shares issued as part of the Company’s $ 2.00 3.00 1,308,750 634,625 3.00 Warrants Issued with Senior Convertible Notes Payable In conjunction with the sale of senior convertible notes payable, the Company issued warrants to purchase an aggregate of 3,591,235 80 115 Warrants Issued under Advisory Board Agreement On July 1, 2021, the Company entered into a three-year consulting agreement (the “Agreement”) for which the consultant is to serve on the Company’s Advisory Board and provide services as defined in the Agreement. Per the terms of the Agreement, the Company is to pay the consultant $ 5,000 100,000 2.00 100,000 2.00 100,000 4.00 100,000 4.00 382,000 2.00 five years 108 0 0.25 During the year ended December 31, 2021, the Company recognized $ 288,000 93,000 Summary of Options 2016 Stock Incentive Plan The Company’s 2016 Equity Incentive Plan (the “Plan”) is for officers, employees, non-employee members of the Board of Directors, and consultants of the Company. The Plan authorized the granting of not more than 1 1 7 A summary of stock options for the year ended December 31, 2021 is as follows: Summary of Options Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2020 - $ - Options granted 4,415,000 2.00 Options exercised - - Options expired or forfeited - - Balance outstanding, December 31, 2021 4,415,000 $ 2.00 Balance exercisable, December 31, 2021 880,417 $ 2.00 Information relating to outstanding options at December 31, 2021, summarized by exercise price, is as follows: Summary of Outstanding Options Exercise Price Outstanding Exercisable Weighted Weighted Exercise Price Life Average Average Per Share Shares (Years) Exercise Price Shares Exercise Price $ 2.00 4,415,000 9.15 $ 2.00 880,417 $ 2.00 During the year ended December 31, 2021, as discussed below, the Company approved options exercisable into 4,415,000 7.6 1.5 6.1 As of December 31, 2021, the outstanding and exercisable options have an intrinsic value of $ 17.7 3.5 6.00 Options Issued under Executive Employment Agreements Chief Executive Officer On March 21, 2021, the Company and Mr. Destler, Chief Executive Officer “(the “Executive”), entered into an amended Employment Agreement (the “Amended Agreement”) (see Note 8). The Amended Agreement granted the Executive an option to purchase 4,000,000 2.00 April 1, 2031 83,333 2.00 6.8 2.00 seven years 107 0 1.34 1.1 Chief Financial Officer and Director of Operations On May 17, 2021, the Company entered into an employment agreement with Steve Handy to serve as its Chief Financial Officer and Director of Operations (the “Employment Agreement”). The term of the employment is for twelve months. Mr. Handy’s base salary is $ 200,000 100,000 The Employment Agreement granted the Executive an option to purchase 300,000 2.00 May 17, 2026 16,666 2.00 462,000 2.00 five years 106 0 0.83 269,000 Employee Option Grants During the year ended December 31, 2021, the Company granted its employees options to purchase an aggregate of 75,000 2.00 2.00 6.67 310,000 4.67 115 0 1.12 61,000 Options Issued under Advisory Board Agreements On August 18, 2021 and September 24, 2021, the Company entered into a one-year consulting agreement (the “Agreement”), with automatic annual renewals, for which the consultants are to serve on the Company’s Advisory Board and provide services as defined in the Agreement. Per the terms of the Agreement, the Company is to pay the consultants an aggregate amount of $ 10,000 40,000 2.00 40,000 53,000 2.00 110 0 0.90 17,000

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended	12 Months Ended
Commitments and Contingencies	Jun. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9 – Commitments and Contingencies Legal Proceedings We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. There is no action, suit, proceeding, inquiry, or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or our subsidiary, threatened against our Company, our common stock, our subsidiary or of our Company or our subsidiary’s officers or directors in their capacities as such. Advisor Agreements On July 14, 2021, the Company entered into a three year consulting agreement (the “Agreement”) for which the consultant is to serve on the Company’s Advisory Board and provide services as defined in the Agreement. Per the terms of the Agreement, the Company issued 12,500 25,000 25,000 30,000 30,000 30,000 3 2.00 ICM Capital Management, LLC On August 24, 2021, the Company entered into an advisor agreement with ICM Capital Management, LLC (“ICM”) regarding the role and compensation of ICM in connection with transactions in which the Company, directly or indirectly through one or more affiliates, raises debt capital or receives a loan from one or more investors identified by ICM to the Company to raise up to $ 2.0 2.0 INTE Securities LLC On August 24, 2021, the Company entered into an advisor agreement with INTE Securities LLC (“INTE”) regarding the role and compensation of INTE in connection with equity transactions in which the Company, in each case directly or indirectly through one or more affiliates, (i) raises equity capital from one or more investors or otherwise issues the Company’s capital stock or (ii) otherwise issues instruments convertible into the Company’s capital stock, with the principal purpose of raising capital from one or more investors identified by INTE to the Company. The advisor agreement shall expire on the date specified by either INTE or the Company not less than 30 days prior to the date of termination. The Company agreed to pay INTE a fee equal to 4.0 Corporate Capital Group, Inc. On April 19, 2022, the Company entered into an advisor agreement (“Agreement”) with Corporate Capital Group, Inc. (“CCG”) to assist the Company as its non-exclusive financial advisor with regard to a proposed capital investment by third parties introduced to the Company by CCG (the “Investors”). This authorization includes the possible sale of any of the Company’s assets including its intellectual property, business or equity, debt or other securities. This authorization covers such a sale by means of any merger, consolidation, recapitalization, joint venture, business combination, exchange offer or purchase or sale or licensing of securities or assets. Also covered by this authorization is any other transaction resulting in a change of control of the Company or its assets, securities or business, the acquisition of any shares of its stock or the disposition outside the ordinary course of business of any of its assets, securities or business. This Agreement shall become effective on the date of execution of this Agreement by the Company (the “Effective Date”) and the term of this Agreement and the appointment provided for herein (the “Term”) shall end at any time after three (3) months following the Effective Date, on thirty days written notice from either party to the other. Compensation for Services 1. The Company agreed to pay CCG a fee of $ 10,000 2. If any Investor Transaction is consummated (a) during the Term with any Investor; or (b) within thirty-six months after the end of the Term with any Investor, then: i) At each closing of an Investor Transaction, the Company shall pay CCG or cause CCG to be paid, a cash fee (the “Investor Transaction Fee”) of seven percent ( 7 ii) In connection with the exercise of any warrants issued to the Investor in connection with the Investor Transactions (the “Investor Warrants”), the Company shall pay CCG or cause CCG to be paid, by wire transfer on the day that the Company receives any payment resulting from the exercise of the Investor Warrants, a cash fee of seven percent ( 7 iii) On completion of any Transaction, the Company shall issue to CCG or its permitted assignees, warrants (the “Agent Warrants”) to purchase seven percent (7%) of the aggregate number of shares of common stock of the Company sold (or issuable upon exercise of any convertible securities sold) in such Investor Transaction at an exercise price equal to one hundred percent ( 100 For the avoidance of doubt only, the Agent Warrants shall represent seven percent (7%) of the stock issued to the Investor and not seven percent (7%) of the total Company equity. The Agent Warrants shall provide for (a) a five (5) year term, and (b) cashless exercise provisions, and (c) piggyback and demand registration rights, and (d) standard anti-dilution protections. The shares of the Common Stock of the Company underlying the Agent Warrants, if any, (and the shares of Common Stock underlying the securities issuable upon exercise of the Agent Warrants) shall be registered in the registration statement, if any, filed in connection with the Investor Transaction Aggregate Consideration is defined and computed as follows: ● The total sale proceeds and other consideration received by the Company and/or holders of its stock, options, warrants and convertible securities upon the consummation of any Transaction, and if a portion of such consideration includes contingent payments, Aggregate Consideration shall also include the face value of such payments as and when they are received by the Company. ● If the Aggregate Consideration for the Transaction consists in whole or in part of securities or other property, for the purposes of calculating the amount of Aggregate Consideration, the value of such securities or other property will be the value thereof on the day preceding the consummation of the Transaction as the Company and CCG agree, provided, however, that in the case of securities for which there is a public trading market, the value will be determined by the average last sales prices for such securities for the last twenty trading days prior to such consummation as determined by CCG. In the case of debt securities for which there is no public trading market, the value thereof shall be the principal amount thereof. If there is no public trading market for securities or other property other than debt securities received or receivable as part of Aggregate Consideration and the parties are unable to agree on their value, then each of CCG and the Company will select an investment banking firm respected in the merger and acquisition field to determine a value and the midpoint between the two values established by the two independent experts will be the fair market value for the purpose hereof. 3. If any Technology Partner Transaction is consummated (a) during the Term with any Technology Partner; or (b) within thirty-six months after the end of the Term with any Technology Partner; then, at each closing of a Technology Partner Transaction, the Company shall pay CCG a cash fee (the “Technology Partner Transaction Fee”) of five percent ( 5 4. The Company agrees to reimburse CCG for all reasonable out-of-pocket expenses incurred in carrying out the terms of this Agreement, including travel and entertainment, courier, and other reasonable expenses. These out-of-pocket expenses shall be payable from time to time upon invoicing by CCG at any time after the commencement of this Agreement, and all invoices shall be payable by the Company within seven (7) days.	Note 9 – Commitment and Contingencies Commitments and Contingencies Legal Proceeding We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or our subsidiary, threatened against our Company, our common stock, our subsidiary or of our Company or our subsidiary’s officers or directors in their capacities as such. Kingdom Building Consulting Agreement On April 1, 2021, the Company entered into a consulting agreement with Kingdom Building, Inc. (“KBI”). For an initial one-year period, with automatic annual extensions thereafter, KBI will advise, counsel and inform designated officers and employees of the Company as it relates to financial markets, competitors, business acquisitions and other aspects of or concerning the Company’s business about which KBI has knowledge or expertise. The Company agreed to pay $ 5,000 5,000 250,000 10,000 50,000 Upon the closing of an investment in the Company of at least $ 5 1.00 5 0.50 Advisory Agreements On July 14, 2021, the Company entered into a three-year consulting agreement (the “Agreement”) for which the consultant is to serve on the Company’s Advisory Board and provide services as defined in the Agreement. Per the terms of the Agreement, the Company issued 12,500 25,000 25,000 30,000 30,000 30,000 3 2.00 On August 24, 2021, the Company entered into an advisor agreement with ICM Capital Management, LLC (“ICM”) regarding the role and compensation of ICM in connection with transactions in which the Company, directly or indirectly through one or more affiliates, raises debt capital or receives a loan from one or more investors identified by ICM to the Company to raise up to $ 2.0 2.0 On August 24, 2021, the Company entered into an advisor agreement with INTE Securities LLC (“INTE”) regarding the role and compensation of INTE in connection with equity transactions in which the Company, in each case directly or indirectly through one or more affiliates, (i) raises equity capital from one or more investors or otherwise issues the Company’s capital stock or (ii) otherwise issues instruments convertible into the Company’s capital stock, with the principal purpose of raising capital from one or more investors identified by INTE to the Company. The advisor agreement shall expire on the date specified by either INTE or the Company not less than 30 days prior to the date of termination. The Company agreed to pay INTE a fee equal to 4.0 Chief Executive Officer Employment Agreement Jonathon Destler, Chief Executive Officer The Company and Jonathan Destler entered into an Employment Agreement (the “Employment Agreement”) dated December 17, 2018, and as amended on March 31, 2021, which provides for an annual base salary of $ 240,000 The salary will increase by 7% on November 1 of each year, based on the salary due in the year prior to each such 7% increase. The Employment Agreement also grants to Mr. Destler an option, dated March 31, 2021, to purchase 4,000,000 2.00 April 1, 2031 83,333 Mr. Destler shall be granted 1,000,000 Mr. Destler may, in his sole discretion, be granted any part of or all such 1,000,000 shares in the form of a warrant or option, exercisable at $ 0.001 1,000,000 5 The Employment Agreement also provides for cash bonus(es), payable to Mr. Destler, equal to 10% of first $ 1,000,000 1,000,000 1,000,000 1,000,000 4,000,000 0.75 The Employment Agreement also provides for a cash fee, payable to Mr. Destler, (i) equal to 3 750,000 6 5,000,000 750,000 The Employment Agreement also obligates us to pay for Mr. Destler’s costs related to his reasonable monthly cell phone and other mobile Internet costs, home office Internet costs, car and commuting costs not to exceed $ 1,000 Mr. Destler is entitled to receive severance benefits upon termination of employment with the Company. Mr. Destler’s entitlement to such severance benefits shall be conditioned upon Mr. Destler’s execution and delivery to us of (i) a general release of all claims, (ii) a resignation from all of Mr. Destler’s positions with us and (iii) an agreement not to directly or indirectly be employed or involved with any business developing or exploiting any products or services that are competitive with products or services (a) being commercially developed or exploited by us during Mr. Destler’s employment and (b) on which Mr. Destler worked or about which Mr. Destler learned proprietary information or trade secrets of us during Mr. Destler’s employment with us. If Mr. Destler voluntarily elects to terminate his employment with us other than by Mr. Destler’s resignation for good reason or if we terminate Mr. Destler’s employment for cause, or Mr. Destler dies or becomes incapacitated or otherwise disabled in such a manner that, in the sole determination of our board of directors, Mr. Destler cannot reasonably perform the duties to us, then Mr. Destler shall not be entitled to receive payment of any severance benefits. Mr. Destler will receive payment for all salary and unpaid vacation accrued as of the date of Mr. Destler’s termination of employment and Mr. Destler’s benefits will be continued solely to the extent of our then existing benefit plans and policies in accordance with such plans and policies in effect on the date of termination. If Mr. Destler’s employment is terminated by us without cause or by Mr. Destler’s resignation for good reason prior to or more than 12 months after, a change of control, Mr. Destler will receive payment for all salary and unpaid vacation accrued as of the date of Mr. Destler’s termination of employment, and, in addition, Mr. Destler will be entitled to receive the following severance benefits: (i) continued payment of his base salary for a period of 12 months following the date of termination, in accordance with our normal payroll practices; (ii) reimbursement of his premium cost for continuation coverage for the lesser of the first 12 months of continuation coverage or that number of months until Mr. Destler becomes eligible for reasonably comparable benefits under any future employer’s health insurance plan, provided Mr. Destler makes a timely election for such continuation coverage and presents reasonably requested documentation of payment of such premiums; (iii) payment of 100 (iv) accelerated vesting as to 50 (v) reimbursement for up to $ 100,000 If Mr. Destler’s employment is terminated by us without cause or by Mr. Destler’s resignation for good reason in either case within 12 months following a change of control, Mr. Destler will receive payment for all salary and unpaid vacation accrued as of the date of Mr. Destler’s termination of employment, and, in addition, Mr. Destler will be entitled to receive the following severance benefits: (i) continued payment of his base salary for a period of 18 months following the date of termination, in accordance with our normal payroll practices; (ii) reimbursement of his premium cost for continuation coverage for the lesser of the first 18 months of continuation coverage or that number of months until Mr. Destler becomes eligible for reasonably comparable benefits under any future employer’s health insurance plan, provided Mr. Destler makes a timely election for such continuation coverage and presents reasonably requested documentation of payment of such premiums; (iii) payment of 150 (iv) accelerated vesting of 100 (v) reimbursement for up to $ 50,000

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Note 10 – Income Taxes At December 31, 2021, the Company had available Federal and state net operating loss carryforwards to reduce future taxable income. The amounts available were approximately $ 16.8 50 Effective January 1, 2007, the Company adopted FASB guidelines that address the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. This guidance also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. At the date of adoption, and as of December 31, 2021 and 2020, the Company did not have a liability for unrecognized tax benefits, and no adjustment was required at adoption. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31, 2021, and 2020, the Company has not accrued interest or penalties related to uncertain tax positions. Additionally, tax years 2018 through 2021 remain open to examination by the major taxing jurisdictions to which the Company is subject. Upon the attainment of taxable income by the Company, management will assess the likelihood of realizing the tax benefit associated with the use of the carryforwards and will recognize the appropriate deferred tax asset at that time. The Company’s effective income tax rate differs from the amount computed by applying the federal statutory income tax rate to loss before income taxes as follows: Schedule of Effective Income Tax Rate December 31, 2021 December 31, 2020 Income tax benefit at federal statutory rate (21.0 )% (21.0 )% State income tax benefit, net of federal benefit (6.0 )% (6.0 )% Change in valuation allowance 27.00 % 27.00 % Income taxes at effective tax rate - % - % The components of deferred taxes consist of the following at December 31, 2020 and 2019: Schedule of Components of Deferred Taxes December 31, 2021 December 31, 2020 Net operating loss carryforwards $ 4,523,000 $ 2,479,000 Less: Valuation allowance (4,523,000 ) (2,479,000 ) Net deferred tax assets $ - $ -

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
Related Party Transactions	Jun. 30, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 10 – Related Party Transactions The Company subleases its office space from an individual who is personally indebted to the Company’s Chief Executive Officer. During the six months ended June 30, 2021, the Company directed rent payments totaling $ 45,000 During the six months ended June 30, 2021, the Company reimbursed the Company’s Chief Executive Officer $ 29,000 Aaron Danks, son of a former director of the Company, was paid for services provided to the Company. Aaron Danks was paid $ 26,000 On May 17, 2021, Mr. Handy was hired by us as our Chief Financial Officer and Director of Operations. Before Mr. Handy’s employment with us, Mr. Handy provided services to us as a consultant to help us prepare for our financial statement audits and prepare our financial statements. During the six months ended June 30, 2021, and prior to his date of employment with the Company, Mr. Handy was paid approximately $ 6,000 On March 15, 2021, we entered into a consulting agreement with Mr. Klausner to provide the services to develop the Company’s financial model and corporate finance strategy and work on such matters as may be requested from time to time by us. The term of the consulting agreement was three months and expired on June 15, 2021. Mr. Klausner received 30,000 60,000	Note 11 – Related Party Transactions Both Yosepha Shahak Ravid and Nicholas Booth are members of DisperSolar LLC, a California limited liability company (“DisperSolar”), and are named inventors of the acquired patents from Dispersolar, discussed below. Effective July 1, 2021, Ms. Shahak Ravid, our Chief Science Officer, and Mr. Booth, our Chief Technology Officer, were employed by us. The Company subleases its office space from an individual who is personally indebted to the Company’s Chief Executive Officer. During the year ended December 31, 2021, the Company directed rent payments totaling $ 45,000 During the year ended December 31, 2021, the Company reimbursed the Company’s Chief Executive Officer $ 29,000 On March 15, 2021, we entered into a consulting agreement with Mr. Klausner to provide the services to develop the Company’s financial model and corporate finance strategy and work on such matters as may be requested from time to time by us. The term of the consulting agreement was three months and expired on June 15, 2021. Mr. Klausner received 30,000 60,000 On May 17, 2021, Mr. Handy was hired by us as our Chief Financial Officer and Director of Operations. Before Mr. Handy’s employment with us, Mr. Handy provided services to us as a consultant to help us prepare for our financial statement audits and prepare our financial statements. During the year ended December 31, 2021, and prior to his date of employment with the Company, Mr. Handy was paid approximately $ 6,000 Aaron Danks, son of a director of the Company, was paid for services provided to the Company. Aaron Danks was paid $ 26,000 2,700 On December 31, 2019, the Company had a due from related parties balance of $ 68,000 68,000 68,000

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
Subsequent Events	Jun. 30, 2022	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11 – Subsequent Events The Company has evaluated subsequent events occurring from July 1, 2022, through the date of this filing. Common Shares Issued on Private Offering Subsequent to June 30, 2022, the Company received net proceeds of approximately $ 1.2 396,668 3.00 198,334 . 3.00 December 31, 2023 4.00 Common Shares Issued for Services Subsequent to June 30, 2022, the Company issued 110,000 330,000 Common Shares Issued on Exercise of Warrants Subsequent to June 30, 2022, the Company received proceeds of approximately $ 40,000 20,000 20,000 2.00 Capital Navigation Strategies On July 29, 2022, the Company entered into an Advisor Agreement (“Agreement”) with Capital Navigation Strategies (“CNS”) to raise capital for the Company on a non-exclusive reasonable best efforts basis, in connection with entering into an agreement to obtain or receive capital, credit, cash advance, prepayments, factor, loan, convertible note, or other debt, equity or funding arrangement, including a hedging arrangement, joint venture, partnership or business collaboration. CNS shall be engaged on a non-exclusive best-efforts basis until the successful completion or closing of the assignment or transaction(s) contemplated by the Agreement. Either party hereto may terminate the Agreement on the earlier of (a) twelve (12) months after the mutual written approval by CNS and the Company of the Company’s teaser, marketing presentation, and virtual due diligence room subject to automatic annual renewal unless terminated in writing by either party or (b) the date on which the Company files a registration statement with the SEC or other regulatory body for an initial public offering, by giving thirty (30) days written notice of such party’s desire to terminate to the other party. If a transaction or any other funding for the Company or a Company project is consummated as identified and listed on Schedule B of the Agreement during the Agreement period or within sixty ( 60 6 280	Note 12 – Subsequent Events The Company has evaluated subsequent events occurring from January 1, 2022, through February 28, 2022, the date of the audit opinion letter. Employee Option Grants Subsequent to December 31, 2021, the Company granted its new employee the option to purchase an aggregate of 50,000 2.00 five years twelve months Loan Payable On January 20, 2022, the Company financed the purchase of a vehicle for $ 49,000 71 15.54 1,066

Inventory

Inventory	6 Months Ended
Inventory	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory	Note 3 – Inventory Inventory, which is comprised of finished product, is valued at the lower of cost (first-in, first-out) or net realizable value, and net of reserves is comprised of the following: Schedule of Inventory June 30, 2022 December 31, 2021 Inventory $ 516,000 $ - Reserve for obsolescence - - Total inventory $ 516,000 $ - During the six months ended June 30, 2022, the Company determined that no reserve for obsolete inventory was necessary. During the six months ended June 30, 2021, the Company recorded a reserve for slow moving and potentially obsolete inventory of $ 45,000

Intangible Assets and Contingen

Intangible Assets and Contingent Earnout Liability	6 Months Ended
Intangible Assets and Contingent Earnout Liability	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Contingent Earnout Liability	Note 5 – Intangible Assets and Contingent Earnout Liability DisperSolar LLC (Related Party) On April 7, 2017 (as amended on December 6, 2018), the Company and DisperSolar LLC (the “Seller”), a California limited liability company, entered into a Patent Purchase Agreement (the “Agreement”) pursuant to which the Company acquired certain patents (intellectual property) of the Seller. The Seller developed the patents for harvesting, transmission, spectral modification and delivery of sunlight to shaded areas of plants. Per the Agreement, the Company was obligated to pay milestone payments, earnout payments, and royalties. Earnout Payments The Company is obligated to pay total earnout payments of $ 800,000 1.6 Royalties The Company will pay to Seller royalties as follows: (i) Following the recognition by the Company of the first $ 1.6 30 (ii) Once the Company has paid to Seller an aggregate amount in royalties of $ 30 4.75 As of June 30, 2022 and December 31, 2021, the Company recorded no earnout or royalties payment obligations as no gross margin was realized. Strategic Transaction The Company will pay to Seller 7.6 Strategic Transaction Consideration. “Strategic Transaction Consideration” means any cash consideration and the fair market value of any non-cash consideration paid to the Company by any acquirer as consideration for the Strategic Transaction, less the costs and expenses incurred by the Company for the purpose of consummating the Strategic Transaction. The Company will pay to Seller a percentage of all license consideration received by the Company as follows: (i) 3.8 50 (ii) 5.7 100 50 150 (iii) 7.6 150 Inventor Royalty (Related Party) On July 5, 2019, the Company and Nicholas Booth (“Mr. Booth”) entered into a Royalty Agreement. Mr. Booth is a member of Dispersolar, LLC and a named inventor of the acquired patents from Dispersolar, LLC discussed above. Effective July 1, 2021, Mr. Booth was employed by the Company as its Chief Technology Officer. The Company will pay Mr. Booth a percentage of all License Consideration received by the Company as follows: (a) Once the Company has paid to DisperSolar an aggregate amount in royalties of $ 30 0.25 (b) Opti-Harvest will pay to Booth a percentage of all License Consideration received by the Company on the same terms as payable by the Company to DisperSolar under the Agreement, except that the percentages of License Consideration due to Booth shall be as follows: (a) 0.4 (b) 0.2 50 (c) 0.3 100 50 150 (d) 0.4 150 As of June 30, 2022 and December 31, 2021, no amounts were due for earnouts or royalties. Both Yosepha Shahak Ravid and Nicholas Booth are members of the Seller, and are named inventors of the acquired patents from the Seller, discussed above. Effective July 1, 2021, Ms. Shahak Ravid, our Chief Science Officer, and Mr. Booth, our Chief Technology Officer, were employed by the Company.

Significant Accounting Polici_2

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended	12 Months Ended
Significant Accounting Policies (Tables)	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of Property and Equipment		Schedule of Estimated Useful Lives of Property and Equipment Property and Equipment Type Years of Depreciation Tool and Molds 2 3 years Vehicle 5 years Office equipment 3 years
Schedule of Anti-Dilutive Securities of Earning Per Share	For the six months ended June 30, 2022 and 2021, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following: Schedule of Anti-Dilutive Securities of Earning Per Share June 30, 2022 June 30, 2021 Warrants 5,870,610 2,264,375 Options 4,540,000 4,325,000 Restricted stock units 200,000 - Senior convertible notes 1,627,522 - Series A Preferred 1 1 Total 12,238,133 6,789,376 Anti-dilutive securities 12,238,133 6,789,376	For the years ended December 31, 2021 and 2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following: Schedule of Anti-Dilutive Securities of Earning Per Share December 31, 2021 December 31, 2020 Warrants 6,578,360 1,278,375 Options 4,415,000 - Senior convertible notes 769,240 - Series A Preferred 1 1 Total 11,762,601 1,278,376

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended	12 Months Ended
Property and Equipment (Tables)	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment is comprised of the following: Schedule of Property and Equipment June 30, 2022 December 31, 2021 Tools and molds $ 1,990,000 $ 1,682,000 Computer equipment 8,000 8,000 Vehicles 113,000 45,000 Total cost 2,111,000 1,735,000 Accumulated depreciation (824,000 ) (577,000 ) Net book value $ 1,287,000 $ 1,158,000	Property and equipment consist of the following at December 31, 2021 and 2020: Schedule of Property and Equipment 2021 2020 Tools and molds $ 1,682,000 $ 592,000 Office equipment 8,000 4,000 Vehicles 45,000 45,000 Total cost 1,735,000 641,000 Less: accumulated depreciation and amortization (577,000 ) (278,000 ) Property and equipment, net $ 1,158,000 $ 363,000

Senior Convertible Notes Paya_2

Senior Convertible Notes Payable and Warrants (Tables)	6 Months Ended	12 Months Ended
Senior Convertible Notes Payable and Warrants (Tables)	Jun. 30, 2022	Dec. 31, 2021
Senior Convertible Notes Payable And Warrants
Schedule of Senior Convertible Notes Payable	Senior convertible notes payable is comprised of the following: Schedule of Senior Convertible Notes Payable June 30, 2022 December 31, 2021 Senior convertible notes payable $ 3,591,000 $ 3,591,000 Less debt discount (819,000 ) (2,326,000 ) Total senior convertible notes payable, net $ 2,772,000 $ 1,265,000	Senior convertible notes payable is comprised of the following: Schedule of Senior Convertible Notes Payable December 31, 2021 December 31, 2020 Senior convertible notes payable $ 3,591,000 $ - Less debt discount (2,326,000 ) - Total senior convertible notes payable, net $ 1,265,000 $ -

Loans payable (Tables)

Loans payable (Tables)	6 Months Ended	12 Months Ended
Loans payable (Tables)	Jun. 30, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Loans Payable	Loans payable is comprised of the following: Schedule of Loans Payable June 30, 2022 December 31, 2021 Loans payable $ 76,000 $ 33,000 Less current portion (13,000 ) (8,000 ) Noncurrent portion $ 63,000 $ 25,000	Schedule of Loans Payable

Shareholders_ Equity (Deficit)

Shareholders’ Equity (Deficit) (Tables)	6 Months Ended	12 Months Ended
Shareholders’ Equity (Deficit) (Tables)	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Summary of Warrants	A summary of warrants for the six months ended June 30, 2022 is as follows: Summary of Warrants Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2021 6,578,360 $ 4.97 Warrants granted 32,500 4.00 Warrants exercised (740,250 ) 2.00 Warrants expired or forfeited - - Balance outstanding, June 30, 2022 5,870,610 $ 3.28 Balance exercisable, June 30, 2022 5,770,610 $ 3.27	A summary of warrants for the years ended December 31, 2021 and 2020, is as follows: Summary of Warrants Weighted Average Number of Exercise Warrants Price Balance outstanding, December 31, 2019 643,750 $ 3.00 Warrants granted 634,625 3.00 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2020 1,278,375 3.00 Warrants granted 5,299,985 5.45 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, December 31, 2021 6,578,360 $ 4.97 Balance exercisable, December 31, 2021 6,378,360 $ 5.00
Summary of Outstanding Warrants Exercise Price		Information relating to outstanding warrants at December 31, 2021, summarized by exercise price, is as follows: Summary of Outstanding Warrants Exercise Price Outstanding Exercisable Exercise Price Per Share Share Life (Years) Weighted Average Exercise Price Shares Weighted Average Exercise Price $ 2.00 200,000 2.50 $ 3.00 200,000 $ 2.00 $ 3.00 2,587,125 1.00 $ 3.00 2,587,125 $ 3.00 $ 4.00 200,000 2.50 $ 4.00 - $ 4.00 $ 6.61 3,591,235 2.76 $ 6.61 3,591,235 $ 6.61 6,578,360 2.06 $ 4.97 6,378,360 $ 5.00
Summary of Options	A summary of stock options for the six months ended June 30, 2022 is as follows: Summary of Options Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2021 4,415,000 $ 2.00 Options granted 175,000 2.00 Options exercised - - Options expired or forfeited (50,000 ) 2.00 Balance outstanding, June 30, 2022 4,540,000 $ 2.00 Balance exercisable, June 30, 2022 1,535,833 $ 2.00	A summary of stock options for the year ended December 31, 2021 is as follows: Summary of Options Weighted Number of Average Options Exercise Price Balance outstanding, December 31, 2020 - $ - Options granted 4,415,000 2.00 Options exercised - - Options expired or forfeited - - Balance outstanding, December 31, 2021 4,415,000 $ 2.00 Balance exercisable, December 31, 2021 880,417 $ 2.00
Summary of Outstanding Options Exercise Price	Information relating to outstanding options at June 30, 2022, summarized by exercise price, is as follows: Summary of Outstanding Options Exercise Price Outstanding Exercisable Weighted Weighted Exercise Price Life Average Average Per Share Shares (Years) Exercise Price Shares Exercise Price $ 2.00 4,540,000 8.52 $ 2.00 1,535,833 $ 2.00 4,540,000 8.52 $ 2.00 1,535,833 $ 2.00	Information relating to outstanding options at December 31, 2021, summarized by exercise price, is as follows: Summary of Outstanding Options Exercise Price Outstanding Exercisable Weighted Weighted Exercise Price Life Average Average Per Share Shares (Years) Exercise Price Shares Exercise Price $ 2.00 4,415,000 9.15 $ 2.00 880,417 $ 2.00

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate	The Company’s effective income tax rate differs from the amount computed by applying the federal statutory income tax rate to loss before income taxes as follows: Schedule of Effective Income Tax Rate December 31, 2021 December 31, 2020 Income tax benefit at federal statutory rate (21.0 )% (21.0 )% State income tax benefit, net of federal benefit (6.0 )% (6.0 )% Change in valuation allowance 27.00 % 27.00 % Income taxes at effective tax rate - % - %
Schedule of Components of Deferred Taxes	The components of deferred taxes consist of the following at December 31, 2020 and 2019: Schedule of Components of Deferred Taxes December 31, 2021 December 31, 2020 Net operating loss carryforwards $ 4,523,000 $ 2,479,000 Less: Valuation allowance (4,523,000 ) (2,479,000 ) Net deferred tax assets $ - $ -

Inventory (Tables)

Inventory (Tables)	6 Months Ended
Inventory (Tables)	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory, which is comprised of finished product, is valued at the lower of cost (first-in, first-out) or net realizable value, and net of reserves is comprised of the following: Schedule of Inventory June 30, 2022 December 31, 2021 Inventory $ 516,000 $ - Reserve for obsolescence - - Total inventory $ 516,000 $ -

Basis of Presentation and Liq_2

Basis of Presentation and Liquidity (Details Narrative) - USD ($)	2 Months Ended	6 Months Ended		12 Months Ended
	Aug. 31, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Net loss		$ 7,717,000	$ 4,729,000	$ 10,053,000	$ 3,284,000
Net cash provided by operating activities		2,534,000	2,858,000	5,303,000	2,504,000
Cash		729,000		1,715,000	403,000
Stockholders' Equity Attributable to Parent		$ 1,828,000	$ (2,010,000)	$ (1,157,000)	$ 29,000	$ (627,000)
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from issuance of private placement	$ 1,105,000

Schedule of Estimated Useful Li

Schedule of Estimated Useful Lives of Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Tools, Dies and Molds [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	2
Tools, Dies and Molds [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	3 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	5 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	3 years

Schedule of Anti-Dilutive Secur

Schedule of Anti-Dilutive Securities of Earning Per Share (Details) - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	12,238,133	6,789,376	11,762,601	1,278,376
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	5,870,610	2,264,375	6,578,360	1,278,375
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	4,540,000	4,325,000	4,415,000
Senior Convertible Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	1,627,522		769,240
Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	1	1	1	1
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	200,000

Significant Accounting Polici_4

Significant Accounting Policies (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Product Information [Line Items]
Research and development expense	$ 1,257,000	$ 1,191,000	$ 2,621,000	$ 1,680,000
Cash, FDIC insured amount			$ 250,000
One Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	24%		45%	92%
Two Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	21%
Three Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	16%
Four Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	12%
Five Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	10%
No Customer [Member] \| Customer Concentration Risk [Member] \| Revenue from Contract with Customer Benchmark [Member]
Product Information [Line Items]
Concentration risk, percentage	10%

Schedule of Property and Equipm

Schedule of Property and Equipment (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Total cost	$ 2,111,000	$ 1,735,000	$ 641,000
Accumulated depreciation	(824,000)	(577,000)	(278,000)
Net book value	1,287,000	1,158,000	363,000
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Total cost	1,990,000	1,682,000	592,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost		8,000	4,000
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Total cost	113,000	45,000	$ 45,000
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost	$ 8,000	$ 8,000

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
Property and Equipment (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Jan. 20, 2022	Nov. 20, 2020
Debt Instrument [Line Items]
Depreciation	$ 247,000	$ 156,000	$ 299,000	$ 265,000
Vendor deposits to property and equipment	$ 247,000
Loans Payable [Member]
Debt Instrument [Line Items]
Face amount					$ 49,000	$ 40,000

Earnout and Royalty Obligatio_2

Earnout and Royalty Obligations (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Revenues	$ 20,000	$ 13,000	$ 40,000	$ 20,000
Advance royalties	1,600,000		1,600,000
Royalty expense			30,000,000
Royalty guarantees commitments amount	30,000,000		30,000,000
Mr. Booth [Member]
Royalty expense	$ 30,000,000		$ 30,000,000
Percentage of consideration received	0.30%		0.30%
Strategic transaction consideration	$ 100,000,000		$ 100,000,000
Concentration risk, percentage	0.25%		0.25%
Minimum [Member] \| Mr. Booth [Member]
Percentage of consideration received	0.20%		0.20%
Strategic transaction consideration	$ 50,000,000		$ 50,000,000
Maximum [Member] \| Mr. Booth [Member]
Percentage of consideration received	0.40%		0.40%
Strategic transaction consideration	$ 150,000,000		$ 150,000,000
License [Member]
Revenues	$ 1,600,000		$ 1,600,000
Percentage of consideration received	7.60%		7.60%
License [Member] \| Mr. Booth [Member]
Percentage of consideration received	0.40%		0.40%
Product [Member] \| Revenue from Contract with Customer Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration risk, percentage	4.75%		4.75%
DisperSolar LLC [Member]
Remaining purchase obligation				$ 100,000
Purchase obligation			$ 100,000
Percentage of consideration received	5.70%		5.70%
Strategic transaction consideration	$ 100,000,000		$ 100,000,000
DisperSolar LLC [Member] \| Minimum [Member]
Percentage of consideration received	3.80%		3.80%
Strategic transaction consideration	$ 50,000,000		$ 50,000,000
DisperSolar LLC [Member] \| Maximum [Member]
Percentage of consideration received	7.60%		7.60%
Strategic transaction consideration	$ 150,000,000		$ 150,000,000
DisperSolar LLC [Member] \| Earnout Payments [Member]
Earnout payments, description	earnout payments of $800,000 payable on the on-going basis at a rate of 50% of gross margin and/or license revenue from the date of the first commercial sale of a covered product or the first receipt by the Company of license revenue		earnout payments of $800,000 payable on the on-going basis at a rate of 50% of gross margin and/or license revenue from the date of the first commercial sale of a covered product or the first receipt by Purchaser of license revenue
Payments to acquire intangible assets	$ 800,000		$ 800,000

Schedule of Senior Convertible

Schedule of Senior Convertible Notes Payable (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Less debt discount	$ (819,000)	$ (2,326,000)	$ 0
Total senior convertible notes payable, net	2,772,000	1,265,000
Senior Notes [Member]
Debt Instrument [Line Items]
Senior convertible notes payable	3,591,000	3,591,000
Less debt discount	(819,000)	(2,326,000)
Total senior convertible notes payable, net	$ 2,772,000	$ 1,265,000

Senior Convertible Notes Paya_3

Senior Convertible Notes Payable and Warrants (Details Narrative)			6 Months Ended		12 Months Ended
	May 16, 2022 USD ($) $ / shares shares	Apr. 01, 2021	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Sep. 24, 2021
Proceeds from warrants					$ 3,591,235
Proceeds from issuance of debt					$ 3,034,000
Debt instrument redemption price percentage					15%
Debt Instrument, Unamortized Discount					$ 539,000
Legal fees					$ 18,000	$ 68,000
Warrants exercisable price percentage					115%
Warrants exercise price \| $ / shares					$ 6.90
Fair value of warrants					$ 13,600,000
Fair value of debt					$ 2,500,000
Exercisable warrant percentage amount					115%
Expected term					3 years
Common stock percentage amount		0.50%			80%
Debt, weighted average interest rate					12%
Long-term debt, term					12 months
Gain loss on equity securities					$ 10,000,000
Warrants description			The shares of common stock underlying the Notes and the Warrants are subject to registration rights, and such shares must be registered within 90 days after the effectiveness of the Company’s initial public offering. If the Company fails to register the shares within 90 days, the Company agreed to pay a penalty of a cash payment equal to 0.02857% of the principal amount and interest due and owing under any Note held by the Holder or that number shares of common stock of the Company equal 1% of the shares of common stock underlying any Note and Warrant held by the Holder, in total amount per week paid in, whichever is greater.		The shares of common stock underlying the Notes and the Warrants are subject to registration rights, and such shares must be registered within 90 days after the effectiveness of the Company’s initial public offering. If the Company fails to register the shares within 90 days, the Company agreed to pay a penalty of a cash payment equal to 0.02857% of the principal amount and interest due and owing under any Note held by the Holder or that number shares of common stock of the Company equal 1% of the shares of common stock underlying any Note and Warrant held by the Holder, in total amount per week paid in, whichever is greater.
Percentage of prorata securities			20%		20%
Original issue discount					$ 539,000
Debt discount stock issued					3,000,000
Amortization of debt discount			$ 1,507,000		713,000
Remaining unamortized discount					2,300,000
Accrued interest			$ 315,000		101,000
Accrued interest					$ 101,000
Shares of common stock potentially issuable \| shares			12,238,133	6,789,376	11,762,601	1,278,376
Legal fees					$ 18,000
Percentage of common stock purchase price			80%		80%
Aggregate value of common stock			$ 195,000	$ 4,794,000		$ 2,513,000
Financing Costs			611,000
Changes in interest payable			214,000
Warrant Holder [Member]
Proceeds from warrants					3,000,000
Fair value of warrants					2,500,000
Original issue discount					539,000
Amortization of debt discount			1,500,000
Remaining unamortized discount			$ 819,000		2,300,000
Legal fees					$ 18,000
Senior Notes [Member]
Shares of common stock potentially issuable \| shares					802,685
Number of shares of common stock \| shares			1,627,522
Warrant [Member]
Warrants exercise price \| $ / shares			$ 2
Common stock percentage amount					80%
Debt Instrument, Description					December 15, 2021. Additionally, each Warrant contains a cashless exercise provision, which is effective if the shares underlying the Warrant are not covered by a registration statement 6 months from the date of issuance of the Warrant.
Fair value of warrants issued					$ 2,500,000
Common Stock [Member]
Warrants exercise price \| $ / shares			$ 2
Number of shares of common stock \| shares			65,000	2,372,000		1,269,250
Aggregate value of common stock
Common Stock [Member] \| Senior Convertible Note Holders [Member]
Share Price \| $ / shares	$ 3
Number of shares of common stock \| shares	203,503
Aggregate value of common stock	$ 611,000
Minimum [Member]
Warrants exercise price \| $ / shares			$ 2
Maximum [Member]
Warrants exercise price \| $ / shares			$ 3
Measurement Input, Commodity Market Price [Member]
Stock price			5		6		2
Measurement Input, Price Volatility [Member]
Stock price					110
Measurement Input, Expected Dividend Rate [Member]
Stock price			0		0		0
Measurement Input, Risk Free Interest Rate [Member]
Stock price			1.63		1.34		0.90
Measurement Input, Risk Free Interest Rate [Member] \| Minimum [Member]
Stock price					0.53
Measurement Input, Risk Free Interest Rate [Member] \| Maximum [Member]
Stock price					0.66
IPO [Member]
Warrants exercise price \| $ / shares					$ 3
Share Price \| $ / shares					3
IPO [Member] \| Convertible Promissory Notes [Member]
Warrants exercise price \| $ / shares					$ 6
Senior Convertible Promissory Notes [Member]
Notes issued			$ 3,591,000		$ 3,591,000
Legal fees					$ 18,000

Note Payable (Details Narrative

Note Payable (Details Narrative) - Notes Payable to Banks [Member] - Paycheck Protection Program Loan [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Apr. 27, 2020
Debt Instrument [Line Items]
Aggregate amount		$ 38,000
Note payable	$ 38,000
Gain on forgiveness of debt	$ 38,000

Loans payable (Details Narrativ

Loans payable (Details Narrative) - USD ($)			6 Months Ended
Loans payable (Details Narrative) - USD ($)	Jan. 20, 2022	Nov. 20, 2020	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Loans payable			$ 76,000	$ 33,000	$ 40,000
Loan payable, current			13,000	8,000	$ 7,000
Automobile Loan [Member]
Debt Instrument [Line Items]
Principal amount	$ 49,000
Debt instrument, term	71 months
Debt principal and interest payments	$ 1,066
Debt interest rate	15.54%
Loans Payable [Member]
Debt Instrument [Line Items]
Principal amount	$ 49,000	$ 40,000
Debt instrument, term		59 months
Debt interest rate		4.49%
Debt principal and interest payments		$ 745
Debt instrument collateral		secured by the purchased vehicle.
Principal payments				$ 7,000
Debt principal payments			$ 6,000

Summary of Warrants (Details)

Summary of Warrants (Details) - $ / shares	6 Months Ended	12 Months Ended
Summary of Warrants (Details) - $ / shares	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants expired or forfeited	(50,000)
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants, Balance outstanding	6,578,360	1,278,375	643,750
Weighted Average Exercise Price, Balance outstanding	$ 4.97	$ 3	$ 3
Warrants granted	32,500	5,299,985	634,625
Weighted Average Exercise Price, granted	$ 4	$ 5.45	$ 3
Warrants exercised	(740,250)
Weighted Average Exercise Price, exercised	$ 2
Warrants expired or forfeited
Weighted Average Exercise Price, expired or forfeited
Warrants, Balance outstanding	5,870,610	6,578,360	1,278,375
Weighted Average Exercise Price, Balance outstanding	$ 3.28	$ 4.97	$ 3
Warrants, Balance exercisable	5,770,610	6,378,360
Weighted Average Exercise Price, Balance exercisable	$ 3.27	$ 5

Summary of Outstanding Warrants

Summary of Outstanding Warrants Exercise Price (Details)	Dec. 31, 2021 USD ($) $ / shares
Class of Warrant or Right [Line Items]
Exercise Price Per Share	$ 6.90
Outstanding share \| $	$ 6,578,360
Life (Years)	2 years 21 days
Weighted Average Exercise Price	$ 4.97
Exercisable share \| $	$ 6,378,360
Exercisable Weighted Average Exercise Price	$ 5
Warrant Exercise Price One [Member]
Class of Warrant or Right [Line Items]
Exercise Price Per Share	$ 2
Outstanding share \| $	$ 200,000
Life (Years)	2 years 6 months
Weighted Average Exercise Price	$ 3
Exercisable share \| $	$ 200,000
Exercisable Weighted Average Exercise Price	$ 2
Warrant Exercise Price Two [Member]
Class of Warrant or Right [Line Items]
Exercise Price Per Share	$ 3
Outstanding share \| $	$ 2,587,125
Life (Years)	1 year
Weighted Average Exercise Price	$ 3
Exercisable share \| $	$ 2,587,125
Exercisable Weighted Average Exercise Price	$ 3
Warrant Exercise Price Three [Member]
Class of Warrant or Right [Line Items]
Exercise Price Per Share	$ 4
Outstanding share \| $	$ 200,000
Life (Years)	2 years 6 months
Weighted Average Exercise Price	$ 4
Exercisable share \| $
Exercisable Weighted Average Exercise Price	$ 4
Warrant Exercise Price Four [Member]
Class of Warrant or Right [Line Items]
Exercise Price Per Share	$ 6.61
Outstanding share \| $	$ 3,591,235
Life (Years)	2 years 9 months 3 days
Weighted Average Exercise Price	$ 6.61
Exercisable share \| $	$ 3,591,235
Exercisable Weighted Average Exercise Price	$ 6.61

Summary of Options (Details)

Summary of Options (Details) - $ / shares	6 Months Ended	12 Months Ended
Summary of Options (Details) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Options, Balance outstanding	4,415,000
Weighted Average Exercise Price, Balance outstanding	$ 2
Options granted	175,000	4,415,000
Weighted Average Exercise Price, granted	$ 2	$ 2
Options exercised
Weighted Average Exercise Price, exercised
Options expired or forfeited	(50,000)
Weighted Average Exercise Price, expired or forfeited	$ 2
Options, Balance outstanding	4,540,000	4,415,000
Weighted Average Exercise Price, Balance outstanding	$ 2	$ 2
Options, Balance exercisable	1,535,833	880,417
Weighted Average Exercise Price, Balance exercisable	$ 2	$ 2

Summary of Outstanding Options

Summary of Outstanding Options Exercise Price (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price Per Share		$ 2
Outstanding, Share	4,540,000	4,415,000
Outstanding, Life (Years)	8 years 6 months 7 days	9 years 1 month 24 days
Outstanding, Weighted Average Exercise Price	$ 2	$ 2
Exercisable, Share	1,535,833	880,417
Exercisable, Weighted Average Exercise Price	$ 2	$ 2
Exercise Price One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 2
Outstanding, Share	4,540,000
Outstanding, Life (Years)	8 years 6 months 7 days
Outstanding, Weighted Average Exercise Price	$ 2
Exercisable, Share	1,535,833
Exercisable, Weighted Average Exercise Price	$ 2

Shareholders_ Equity (Deficit_2

Shareholders’ Equity (Deficit) (Details Narrative)									1 Months Ended		2 Months Ended		6 Months Ended		12 Months Ended
Shareholders’ Equity (Deficit) (Details Narrative)	May 16, 2022 USD ($) $ / shares shares	May 09, 2022 USD ($)	Mar. 17, 2022 USD ($) shares	Jul. 02, 2021 USD ($)	May 17, 2021 $ / shares	May 02, 2021 shares	Apr. 01, 2021 USD ($)	Mar. 17, 2021 USD ($) $ / shares shares	Sep. 24, 2021 USD ($) $ / shares shares	May 17, 2021 USD ($) $ / shares	Aug. 31, 2022 USD ($) $ / shares shares	Aug. 31, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 01, 2022 $ / shares	Sep. 01, 2022 $ / shares	Jul. 01, 2022 shares	Dec. 01, 2021 $ / shares shares	Jul. 13, 2021 shares	Jul. 01, 2021 $ / shares shares	May 01, 2021 $ / shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized \| shares													100,000,000		100,000,000	100,000,000
Common stock par value \| $ / shares													$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares authorized \| shares													1,000,000		1,000,000	1,000,000
Preferred stock par value \| $ / shares													$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares issued \| shares													33,736,399		32,405,146	28,956,158
Common stock, shares outstanding \| shares													33,736,399		32,405,146	28,956,158
Net proceeds from common stock													$ 195,000	$ 4,794,000	$ 5,245,000	$ 2,513,000
Warrants exercise price \| $ / shares															$ 6.90
Number of shares issued service \| shares													122,500
Share based compensation													$ 968,000	1,652,000	$ 1,744,000	$ 115,000
Common stock percentage amount							0.50%								80%
Employee benefit plan															$ 7,600,000
Expected term															3 years
Share based compensation expense															$ 1,500,000
Shares of common stock \| shares															4,415,000
Intrinsic value \| shares													4,540,000		4,415,000
Intrinsic value \| shares
Estimated market value \| $ / shares													$ 2		$ 2
Proceeds from warrants															$ 3,591,235
Aggregate value of common stock													$ 195,000	4,794,000		$ 2,513,000
Financing Costs													$ 611,000
Exercise price \| $ / shares													$ 2		$ 2
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock price \| $ / shares													$ 2		$ 2								$ 2
Employee benefit plan															$ 6,800,000
Share based compensation expense															$ 6,100,000
Shares of common stock \| shares						83,333							75,000		75,000
Intrinsic value \| shares															17,700,000
Intrinsic value \| shares															3,500,000
Estimated market value \| $ / shares															$ 6
Intrinsic value													$ 4,540,000	$ 1,536,000
Exercise price \| $ / shares													$ 3
Share based compensation													$ 1,337,000
Stock or Unit Option Plan Expense													$ 5,269,000
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares													$ 2
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares													$ 3
2016 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Restricted shares \| shares															1,000,000
2016 Equity Incentive Plan [Member] \| Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized \| shares																					1,000,000
2016 Equity Incentive Plan [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized \| shares																					7,000,000
2022 Stock Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of share issued \| shares													0
Employee Benefits and Share-Based Compensation													$ 75,000
Aggregate value of common stock			$ 600,000
Shares issued \| shares			200,000
Proceeds from issuance initial public offering			$ 10,000,000
Share based payment options non vested													$ 525,000
Measurement Input, Commodity Market Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate									2				5		6
Measurement Input, Commodity Market Price [Member] \| Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															2
Measurement Input, Commodity Market Price [Member] \| 2016 Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															4.67
Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term															7 years
Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate									110				115		107
Measurement Input, Option Volatility [Member] \| 2016 Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															115
Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate									0				0		0
Measurement Input, Expected Dividend Rate [Member] \| 2016 Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															0
Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate									0.90				1.63		1.34
Measurement Input, Risk Free Interest Rate [Member] \| Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															0.53
Measurement Input, Risk Free Interest Rate [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															0.66
Measurement Input, Risk Free Interest Rate [Member] \| 2016 Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															1.12
Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of share issued \| shares												20,000
Warrants exercise price \| $ / shares											$ 2	$ 2
Number of warrant issued \| shares											20,000	20,000
Proceeds from warrants												$ 40,000
Proceeds from Issuance of Private Placement											$ 1,105,000
Advisory Board Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Employee benefit plan				$ 382,000
Share based compensation expense															$ 288,000
Advisory Board Agreement [Member] \| Measurement Input, Commodity Market Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															2
Advisory Board Agreement [Member] \| Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term															5 years
Advisory Board Agreement [Member] \| Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															108
Share based compensation expense															$ 93,000
Advisory Board Agreement [Member] \| Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															0
Advisory Board Agreement [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate															0.25
Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued service \| shares									40,000
Share based compensation									$ 53,000
Sale of stock price \| $ / shares									$ 2
Other expenses									$ 10,000
Number of shares sales \| shares									40,000
Consultants [Member] \| Advisory Board Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares																				$ 2		$ 2
Number of warrant issued \| shares																				100,000		100,000
Other expenses				$ 5,000
Consultants [Member] \| Advisory Board Agreement [Member] \| Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares																	$ 4	$ 4
Number of warrant issued \| shares																			100,000
Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued price per share \| $ / shares															$ 2.05	$ 2
Number of shares issued service \| shares														826,000	851,488	57,500
Share based compensation													$ 368,000	$ 1,700,000	$ 1,700,000	$ 115,000
Consultants [Member] \| Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued service \| shares												110,000
Consultants [Member] \| Termination Agreement [Member] \| Kingdom Building Inc [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued service \| shares													200,000
Share based compensation													$ 600,000
Chief Executive Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation expense															$ 1,100,000
Chief Executive Officer [Member] \| Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock price \| $ / shares															$ 2
Shares of common stock \| shares															4,000,000
Expire date															Apr. 01, 2031
Chief Executive Officer [Member] \| Employement Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold		$ 220,000
Chief Financial Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation expense															$ 269,000
Shares of common stock \| shares								16,666
Base salary								$ 200,000
Severance payment								$ 100,000
Chief Financial Officer [Member] \| Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock price \| $ / shares					$ 2			$ 2		$ 2
Employee benefit plan										$ 462,000
Shares of common stock \| shares								300,000
Expire date					May 17, 2026
Chief Financial Officer [Member] \| Measurement Input, Commodity Market Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate								2
Chief Financial Officer [Member] \| Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term					5 years
Chief Financial Officer [Member] \| Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate								106
Chief Financial Officer [Member] \| Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate								0
Chief Financial Officer [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate								0.83
Officer [Member] \| Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Employee benefit plan													$ 306,000		$ 310,000
Weighted average expiration period															6 years 8 months 1 day
Mr. Handys [Member] \| Employement Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Severance payment		100,000
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrants]		$ 220,000
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net proceeds from common stock														$ 4,800,000	$ 5,200,000	$ 2,500,000
Number of share issued \| shares													65,000	2,372,000	2,597,500	1,269,250
Shares issued price per share \| $ / shares													$ 3	$ 2	$ 2
Warrants exercise price \| $ / shares													$ 4	$ 3	$ 3
Expiration date															Dec. 31, 2022
Proceeds from warrants													$ 1,500,000
Common stock warrant share \| shares													32,500
Proceeds from Issuance of Private Placement													$ 195,000
Warrant expires date													Dec. 31, 2023	Dec. 31, 2022
Private Placement [Member] \| Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net proceeds from common stock												$ 1,200,000
Shares issued price per share \| $ / shares											$ 3	$ 3
Warrants exercise price \| $ / shares											$ 4	$ 4
Expiration date												Dec. 31, 2023
Number of warrant issued \| shares											198,334	198,334
Number of shares sales \| shares												396,668
IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares															$ 3
Share Price \| $ / shares															$ 3
Proceeds from issuance initial public offering							$ 5,000,000
Employee Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation expense															$ 61,000
Employee Benefits and Share-Based Compensation															$ 17,000
Series A Preferred Stocks [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares desginated \| shares															1
Preferred stock, shares issued \| shares															1
Preferred stock, shares outstanding \| shares															1
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares													$ 2
Number of warrant issued \| shares													740,250		5,299,985
Weighted-average remaining contractual life															2 years 21 days
Outstanding intrinsic value															$ 8,200,000
Exercisable intrinsic value															$ 7,900,000
Estimated market value \| $ / shares															$ 6
Sale of stock price \| $ / shares															2
Common shares purchased \| $ / shares															$ 3
Warrants to purchase, shares \| shares															1,308,750	634,625
Exercise price \| $ / shares															$ 3
Warrants purchase \| shares															3,591,235
Common stock percentage amount															80%
Proceeds from warrant exercises													$ 1,500,000
Warrant [Member] \| Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Intrinsic value													$ 200,000
Exercise price \| $ / shares													$ 3
Warrant [Member] \| Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share Price \| $ / shares													$ 2
Warrant [Member] \| Measurement Input, Commodity Market Price [Member] \| Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate													3
Warrant [Member] \| Measurement Input, Option Volatility [Member] \| Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate													108
Warrant [Member] \| Measurement Input, Expected Dividend Rate [Member] \| Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate													0
Warrant [Member] \| Measurement Input, Risk Free Interest Rate [Member] \| Stock Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Risk-free interest rate													2.81
Warrant [Member] \| IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrants exercisable															115%
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of share issued \| shares													65,000	2,372,000		1,269,250
Warrants exercise price \| $ / shares													$ 2
Number of shares issued service \| shares													322,500	826,000	851,488	57,500
Share based compensation
Intrinsic value \| shares													740,250
Aggregate value of common stock
Common Stock [Member] \| Senior Convertible Note Holders [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of share issued \| shares	203,503
Aggregate value of common stock	$ 611,000
Share Price \| $ / shares	$ 3
Common Stock [Member] \| Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares													$ 2
Common stock warrant share \| shares													740,250
Deferred Compensation, Share-Based Payments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation													$ 66,000
Share based payment options non vested													$ 27,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)

2 Months Ended

6 Months Ended

12 Months Ended

Jul. 01, 2023

Jan. 01, 2023

Jul. 01, 2022

Jan. 01, 2022

Aug. 24, 2021

Jul. 14, 2021

Apr. 01, 2021

Aug. 31, 2022

Jun. 30, 2022

Jun. 30, 2021

Dec. 31, 2021

Dec. 31, 2020

Professional fees

$ 18,000

$ 68,000

Common stock, outstanding percentage

Common stock percentage amount

0.50%

80%

Fair value of common shares issued for services, shares

122,500

Debt instrument redemption price percentage

15%

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 6.90

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross

175,000

4,415,000

Gross profit

$ (6,000)

$ (37,000)

$ (62,000)

$ (95,000)

Other commitment dueIn fourth year

$ 10,000

Stockholders equity description

For the avoidance of doubt only, the Agent Warrants shall represent seven percent
(7%) of the stock issued to the Investor and not seven percent (7%) of the total Company
equity. The Agent Warrants shall provide for (a) a five (5) year term, and (b) cashless exercise
provisions, and (c) piggyback and demand registration rights, and (d) standard anti-dilution
protections. The shares of the Common Stock of the Company underlying the Agent Warrants,
if any, (and the shares of Common Stock underlying the securities issuable upon exercise
of the Agent Warrants) shall be registered in the registration statement, if any, filed in
connection with the Investor Transaction

Fees percentage

Warrant [Member]

Common stock percentage amount

80%

Share price

$ 3

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 2

Investors [Member]

Ownership percentage

Investors [Member] | Warrant [Member]

Ownership percentage

100%

Investor Warrants [Member]

Ownership percentage

Maximum [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 3

Minimum [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 2

Mr. Destler [Member]

Common stock, dividends per share

$ 0.75

Cash fee payable, percentage

License transaction fee, percentage

Mr. Destler [Member] | Previously Reported [Member]

Discretionary cash bonus, percentage

100%

Unvested option shares, percentage

50%

Mr. Destler [Member] | Revision of Prior Period, Adjustment [Member]

Discretionary cash bonus, percentage

150%

Unvested option shares, percentage

100%

Mr. Destler [Member] | Office Equipment [Member]

Costs and expenses

$ 1,000

Mr. Destler [Member] | Maximum [Member]

Gross profit

4,000,000

License transaction fee

750,000

Mr. Destler [Member] | Maximum [Member] | Previously Reported [Member]

Reimbursement expenses

100,000

Mr. Destler [Member] | Maximum [Member] | Revision of Prior Period, Adjustment [Member]

Reimbursement expenses

50,000

Mr. Destler [Member] | Share-Based Payment Arrangement, Tranche One [Member]

Gross profit

1,000,000

Mr. Destler [Member] | Share-Based Payment Arrangement, Tranche Two [Member]

Gross profit

1,000,000

Mr. Destler [Member] | Share-Based Payment Arrangement, Tranche Three [Member]

Gross profit

1,000,000

Mr. Destler [Member] | Share Based Compensation Award Tranche Four [Member]

Gross profit

1,000,000

Chief Executive Officer [Member] | Maximum [Member]

License transaction fee

750,000

Chief Executive Officer [Member] | Minimum [Member]

License transaction fee

$ 5,000,000

Subsequent Event [Member]

Common shares issued in private offerings, shares

20,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 2

IPO [Member]

Proceeds from Issuance Initial Public Offering

$ 5,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 3

Investor [Member]

Proceeds from related party debt

$ 2,000,000

5,000,000

Debt instrument redemption price percentage

INTE Securities LLC [Member]

Principal amounta redeemed

Kingdom Building Consulting Agreement [Member]

Professional fees

5,000

Deferred consulting fees

5,000

Deferred financing cost

250,000

Monthly fee for remaining period

$ 10,000

Sale of stock number of shares, issued

50,000

Consulting Agreement [Member]

Restricted stock issue, shares

12,500

Fair value of common shares issued for services, shares

25,000

Sharebased compensation shares authorized

3 years

Share price

$ 2

Stock issued during period shares restricted

12,500

Stock issued during period value restricted stock award net of forfeitures

$ 25,000

Consulting Agreement [Member] | January 1, 2022 [Member]

Common shares issued in private offerings, shares

25,000

Consulting Agreement [Member] | July 1, 2022 [Member]

Common shares issued in private offerings, shares

30,000

Consulting Agreement [Member] | January 1, 2023 [Member]

Common shares issued in private offerings, shares

30,000

Consulting Agreement [Member] | July 1, 2023 [Member]

Common shares issued in private offerings, shares

30,000

Consulting Agreement [Member] | Forecast [Member]

Fair value of common shares issued for services, shares

30,000

Common shares issued in private offerings, shares

30,000

Consulting Agreement [Member] | Subsequent Event [Member]

Fair value of common shares issued for services, shares

30,000

Employment Agreement [Member]

Increase in salary employment, description

The salary will increase by 7% on November
1 of each year, based on the salary due in the year prior to each such 7% increase.

Employment Agreement [Member] | Mr. Destler [Member]

Common shares issued in private offerings, shares

1,000,000

Annual base salary

$ 240,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 0.001

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross

1,000,000

Stock option, description

Mr. Destler may, in his sole discretion, be granted any part of or all such 1,000,000 shares in the form of a warrant
or option, exercisable at $0.001 per share, for the purchase of 1,000,000 shares of our common stock, for a term of five (5) years. Mr.
Destler’s grant of and right to such 1,000,000 shares is conditioned upon and subject to Mr. Destler being an employee, officer
or director of the Company at the time that the Company’s shares of common stock are listed on the Nasdaq or New York Stock Exchange.

Common stock, term

5 years

Equity Incentive Plan [Member]

Stock option shares to purchase common stock

4,000,000

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 2

Stock option, expiration date

Apr. 01, 2031

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares

83,333

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate (Details)	12 Months Ended
Schedule of Effective Income Tax Rate (Details)	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax benefit at federal statutory rate	(21.00%)	(21.00%)
State income tax benefit, net of federal benefit	(6.00%)	(6.00%)
Change in valuation allowance	27%	27%
Income taxes at effective tax rate

Schedule of Components of Defer

Schedule of Components of Deferred Taxes (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 4,523,000	$ 2,479,000
Less: Valuation allowance	(4,523,000)	(2,479,000)
Net deferred tax assets

Income Taxes (Details Narrative

Income Taxes (Details Narrative) $ in Millions	12 Months Ended
Income Taxes (Details Narrative) $ in Millions	Dec. 31, 2021 USD ($)
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Federal state and local tax, expense	$ 16.8
Maximum [Member] \| Sharehilders [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Equity ownership, percentage	50%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)		6 Months Ended		12 Months Ended
Related Party Transactions (Details Narrative) - USD ($)	Mar. 15, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Stock issued during period shares issued for services		122,500
Stock issued during period value issued for services		$ 968,000	$ 1,652,000	$ 1,744,000	$ 115,000
Due from relatedParties						$ 68,000
Professional services, fee				18,000	68,000
Mr. Destler [Member]
Related Party Transaction [Line Items]
Payments for rent			45,000	45,000
Due from relatedParties						$ 68,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Repayments of related party debt				29,000
Mr Klausner [Member]
Related Party Transaction [Line Items]
Stock issued during period shares issued for services	30,000
Stock issued during period value issued for services	$ 60,000
Mr. Handy [Member]
Related Party Transaction [Line Items]
Related party transaction due from to related party			6,000	6,000
Aaron Danks [Member]
Related Party Transaction [Line Items]
Stock issued during period value issued for services			26,000
Other expenses				$ 26,000
Received insurance premium					$ 2,700
Board of Directors Chairman [Member]
Related Party Transaction [Line Items]
Repayments of related party debt			$ 29,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)				2 Months Ended		6 Months Ended		12 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Jul. 29, 2022	Jan. 20, 2022	Jan. 20, 2022	Aug. 31, 2022	Feb. 28, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Proceeds from issuance of common stock						$ 195,000	$ 4,794,000	$ 5,245,000	$ 2,513,000
Warrants exercise price								$ 6.90
Stock issued during period shares issued for services						122,500
Stock issued during period value issued for services						$ 968,000	$ 1,652,000	$ 1,744,000	$ 115,000
Proceed from exercise of warrants								$ 3,591,235
Consultants [Member]
Subsequent Event [Line Items]
Shares issued price per share								$ 2.05	$ 2
Stock issued during period shares issued for services							826,000	851,488	57,500
Stock issued during period value issued for services						$ 368,000	$ 1,700,000	$ 1,700,000	$ 115,000
Private Placement [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock							$ 4,800,000	$ 5,200,000	$ 2,500,000
Shares issued price per share						$ 3	$ 2	$ 2
Class of warrant or right expiration date								Dec. 31, 2022
Warrants exercise price						$ 4	$ 3	$ 3
Proceed from exercise of warrants						$ 1,500,000
Common shares issued in private offerings, shares						65,000	2,372,000	2,597,500	1,269,250
Automobile Loan [Member]
Subsequent Event [Line Items]
Face amount		$ 49,000	$ 49,000
Loan term			71 months
Annual interest, rate		15.54%	15.54%
Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares granted					50,000
Exercise price per share					$ 2
Expiration period					5 years
Vesting period					12 months
Purchase of warrant				20,000
Warrants exercise price				$ 2
Proceed from exercise of warrants				$ 40,000
Common shares issued in private offerings, shares				20,000
Debt instrument maturity date description	60
Debt instrument interest rate stated percentage	6%
Proceeds from contributed capital	$ 280
Subsequent Event [Member] \| Consultants Agreement [Member]
Subsequent Event [Line Items]
Stock issued during period value issued for services				$ 330,000
Subsequent Event [Member] \| Consultants [Member]
Subsequent Event [Line Items]
Stock issued during period shares issued for services				110,000
Subsequent Event [Member] \| Private Placement [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock				$ 1,200,000
Stock issued during period shares new issues				396,668
Shares issued price per share				$ 3
Purchase of warrant				198,334
Class of warrant or right expiration date				Dec. 31, 2023
Warrants exercise price				$ 4
Subsequent Event [Member] \| Automobile Loan [Member]
Subsequent Event [Line Items]
Face amount		$ 49,000	$ 49,000
Loan term		71 months
Annual interest, rate		15.54%	15.54%
Principal and interest, payments		$ 1,066

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory	$ 516,000
Reserve for obsolescence
Total inventory	$ 516,000

Inventory (Details Narrative)

Inventory (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
Inventory (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory write down		$ 45,000	$ 60,000

Schedule of Loans Payable (Deta

Schedule of Loans Payable (Details) - USD ($)	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Loans payable	$ 76,000	$ 33,000
Less current portion	(13,000)	(8,000)	$ (7,000)
Noncurrent portion	$ 63,000	$ 25,000	$ 33,000

Intangible Assets and Conting_2

Intangible Assets and Contingent Earnout Liability (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Revenues	$ 20,000	$ 13,000	$ 40,000	$ 20,000
Advance royalties	1,600,000		1,600,000
Royalty guarantees commitments amount	$ 30,000,000		30,000,000
Royalty expense			$ 30,000,000
Mr. Booth [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	0.30%		0.30%
Strategic transaction consideration	$ 100,000,000		$ 100,000,000
Royalty expense	$ 30,000,000		$ 30,000,000
Concentration risk, percentage	0.25%		0.25%
Minimum [Member] \| Mr. Booth [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	0.20%		0.20%
Strategic transaction consideration	$ 50,000,000		$ 50,000,000
Maximum [Member] \| Mr. Booth [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	0.40%		0.40%
Strategic transaction consideration	$ 150,000,000		$ 150,000,000
License [Member]
Finite-Lived Intangible Assets [Line Items]
Revenues	$ 1,600,000		$ 1,600,000
Percentage of consideration received	7.60%		7.60%
License [Member] \| Mr. Booth [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	0.40%		0.40%
Product [Member] \| Revenue from Contract with Customer Benchmark [Member] \| Customer Concentration Risk [Member]
Finite-Lived Intangible Assets [Line Items]
Concentration risk, percentage	4.75%		4.75%
DisperSolar LLC [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	5.70%		5.70%
Strategic transaction consideration	$ 100,000,000		$ 100,000,000
DisperSolar LLC [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	3.80%		3.80%
Strategic transaction consideration	$ 50,000,000		$ 50,000,000
DisperSolar LLC [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Percentage of consideration received	7.60%		7.60%
Strategic transaction consideration	$ 150,000,000		$ 150,000,000
DisperSolar LLC [Member] \| Earnout Payments [Member]
Finite-Lived Intangible Assets [Line Items]
Earnout payments, description	earnout payments of $800,000 payable on the on-going basis at a rate of 50% of gross margin and/or license revenue from the date of the first commercial sale of a covered product or the first receipt by the Company of license revenue		earnout payments of $800,000 payable on the on-going basis at a rate of 50% of gross margin and/or license revenue from the date of the first commercial sale of a covered product or the first receipt by Purchaser of license revenue
Payments to acquire intangible assets	$ 800,000		$ 800,000